地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18372041646
传真:18372041646
邮箱:sales@amyjet.com

艾美捷科技代理Epitope Diagnostics全系列抗体及试剂盒产品。
Epitope Diagnostics是一家经过ISO 13845认证的医疗器械制造公司,位于圣地亚哥的索伦托谷生物技术中心。Epitope专门从事全球医疗设备和诊断行业的分析开发和制造。公司涉足领域包括胃肠道,心血管,感染和自身免疫性疾病,以及肿瘤/癌症和钙/骨代谢。Epitope Diagnostics Inc. (EDI) strives to develop, manufacture, and market the highest quality and most innovated in-vitro diagnostics (IVD) products to the global research, pharmaceutical, and healthcare community. We seek to become a major contributor in resolving the unmet medical needs of the world.
Epitope Diagnostics公司的主要产品包括:
| ANTIBODIES | ||
| MAB30699 | Anti-MMAE Monoclonal Antibody | |
| MAB30699b | Biotinylated Anti-MMAE Monoclonal Antibody | |
| MAB30700 | Anti-MMAF Monoclonal Antibody | |
| MAB30700b | Biotinylated Anti-MMAF Monoclonal Antibody | |
| 30698 | Anti-DM1 Polyclonal Antibody | |
| 30699 | Anti-MMAE Polyclonal Antibody | |
| 30700 | Anti-MMAE Polyclonal Antibody | |
| 30618 | Anti-Human FGF-21 N-terminal Specific Antibody, Affinity Purified | |
| 30661 | Anti-Human FGF-21 C-terminal Specific Antibody, Affinitiy Purified | |
| 30704 | Anti-Human Chromogranin A Monoclonal Antibody, Murine | |
| 30705 | Anti-Human Chromogranin A Polyclonal Antibody, Sheep | |
| 30706 | Anti-Human Chromogranin A N-terminal Polyclonal Antibody, Rabbit | |
| 30713 | Anti-Human Chromogranin A N/mid-regional Polyclonal Antibody, Rabbit | |
| 30714 | Anti-Human Chromogranin A C/mid-regional Polyclonal Antibody, Rabbit | |
| 30715 | Anti-Human Chromogranin A C-terminal Polyclonal Antibody, Rabbit | |
| 30657 | Anti-Human NGAL Polyclonal Antibody (IgG), Sheep | |
| 30658 | Anti-Human NGAL Polyclonal Antibody, Sheep, Affinity Purified | |
| TUMOR MARKERS & CANCER RESEARCH | ||
| KT-810 | Human Pepsinogen I ELISA Kit | 96 tests/kit |
| KT-811 | Human Pepsinogen II ELISA Kit | 96 tests/kit |
| KT-812 | Human Chromogranin A ELISA Kit (1st generation) | 96 tests/kit |
| KT-820 | Human Chromogranin A ELISA Kit (2nd generation) | 96 tests/kit |
| KT-855 | Human Chromogranin A ELISA Kit (2nd generation, wide range) | 96 tests/kit |
| KT-817 | Human Neuron Specific Enolase ELISA Kit | 96 tests/kit |
| KT-850 | q-FOB™ Quantitative Fecal Occult Blood Test ELISA Kit | 96 tests/kit |
| 30210 | Fecal Sample Collection Device for q-FOB™ | 50 tubes/kit |
| KT-111 | FOB Cassette Test Kit | 20 tests/kit |
| KT-705 | Intact Brentuximab Vedotin ELISA KIt | 96 tests/kit |
| KT-706 | Trastuzumab Emtansine EIA Kit | 96 tests/kit |
| KTR-755 | Humanized Anti-Her2/neu (Herceptin/trastuzumab) ELISA Kit | 96 tests/kit |
| KTR-756 | DM1 ADC EIA Kit | 96 tests/kit |
| KTR-757 | MMAE ADC EIA Kit | 96 tests/kit |
| KTR-758 | MMAF ADC EIA Kit | 96 tests/kit |
| KTR-782 | Intact MMAE ADC ELISA Kit | 96 tests/kit |
| KTR-783 | Intact MMAF ADC ELISA Kit | 96 tests/kit |
| GASTROINTESTINAL DISEASE-Serum ELISA Kits | ||
| KT-810 | Human Pepsinogen I ELISA Kit | 96 tests/kit |
| KT-811 | Human Pepsinogen II ELISA Kit | 96 tests/kit |
| KT-830 | Human Anti-Gliadin IgA EIA Kit | 96 tests/kit |
| KT-831 | Human Anti-Gliadin IgG EIA Kit | 96 tests/kit |
| KT-845 | Human Anti-Giardia lamblia IgA ELISA Kit | 96 tests/kit |
| KT-846 | Human Anti-Giardia lamblia IgG ELISA Kit | 96 tests/kit |
| KT-847 | Human Anti-Giardia lamblia IgM ELISA Kit | 96 tests/kit |
| GASTROINTESTINAL DISEASE-Fecal ELISA Kits | ||
| KT-824 | Qualitative Fecal H. pylori Antigen ELISA Kit | 96 tests/kit |
| KT-826 | Quantitative Fecal H. pylori Antigen ELISA Kit | 96 tests/kit |
| KT-828 | Fecal C. difficile GDH ELISA Kit | 96 tests/kit |
| KT-834 | Fecal C. difficile Toxin A ELISA Kit | 96 tests/kit |
| KT-835 | Fecal C. difficile Toxin B ELISA Kit | 96 tests/kit |
| KT-836 | Fecal C. difficile Toxin A & B ELISA Kit | 96 tests/kit |
| KT-837 | Fecal E. coli 0157 ELISA Kit | 96 tests/kit |
| KT-838 | Fecal Giardia lamblia Antigen ELISA Kit | 96 tests/kit |
| KT-839 | Fecal Cryptosporidium parvum Antigen ELISA Kit | 96 tests/kit |
| KT-841 | Fecal Rotavirus Antigen ELISA Kit | 96 tests/kit |
| KT-842 | Fecal Adenovirus Antigen ELISA Kit | 96 tests/kit |
| KT-849 | Quantitative Fecal Calprotectin ELISA Kit | 96 tests/kit |
| KT-850 | q-FOB™ Quantitative Fecal Occult Blood Test ELISA Kit | 96 tests/kit |
| KT-853 | Quantitative Fecal NGAL ELISA Kit | 96 tests/kit |
| KT-880 | Quantitative Fecal/Urine Myeloperoxidase ELISA Kit | 96 tests/kit |
| GASTROINTESTINAL DISEASE-Fecal Sample Collection Kits | ||
| KT-854 | Fecal H. pylori Sample Collection Kit | 50 tubes/kit |
| KT-864 | Fecal H. pylori/GDH/Toxin A&B Sample Collection Kit | 48 tubes/kit |
| KT-843 | Fecal Calprotectin Sample Collection Kit | 50 tubes/kit |
| 30210 | q-FOB™ Fecal Sample Collection Device | 50 tubes/kit |
| KT-844 | Fecal MPO Sample Collection Kit | 48 tubes/kit |
| KT-884 | Fecal NGAL Sample Collection Kit | 48 tubes/kit |
| FPC200 | Fecal Ova/Parasite Concentration Kit | 50 tubes/kit |
| GASTROINTESTINAL DISEASE-Rapid Tests | ||
| KT-313 | EpiTuub® Immunochemical Fecal Occult Blood Rapid Test Kit | 30 tests/kit |
| KT-917 | EpiTuub® Fecal Rotavirus Antigen Rapid Test Kit | 30 tests/kit |
| KT-918 | EpiTuub® Fecal Adenovirus Antigen Rapid Test Kit | 30 tests/kit |
| KT-920 | EpiTuub® Fecal Calprotectin Rapid Test Kit | 30 tests/kit |
| KT-921 | EpiTuub® Fecal Calprotectin Rapid Test Kit | 10 tests/kit |
| KT-922 | EpiTuub® Calprotectin/i-FOB DUO Test | 30 tests/kit |
| KT-926 | EpiTuub® Fecal Rota-Adeno Duo Antigen Rapid Test Kit | 30 tests/kit |
| KT-927 | EpiTuub® Fecal Giardia lamblia Antigen Rapid Test Kit | 30 tests/kit |
| KT-928 | EpiTuub® Fecal Cryptosporidiun parvum Antigen Rapid Test Kit | 30 tests/kit |
| KT-929 | EpiTuub® Fecal H. pylori Antigen Rapid Test Kit | 30 tests/kit |
| KT-935 | EpiTuub® Fecal C. difficile Antigen Rapid Test Kit | 30 tests/kit |
| GASTROINTESTINAL DISEASE-Strip Test Kit | ||
| KT-313s | Immunochemical Fecal Occult Blood Strip Test Kit | 50 strips/kit |
| KT-917s | Fecal Rotavirus Antigen Strip Test Kit | 50 strips/kit |
| KT-918s | Fecal Adenovirus Antigen Strip Test Kit | 50 strips/kit |
| KT-920s | Fecal Calprotectin Strip Test Kit | 50 strips/kit |
| KT-927s | Fecal Giardia lamblia Antigen Strip Test Kit | 50 strips/kit |
| KT-928s | Fecal Cryptosporidium parvum Antigen Strip Test Kit | 50 strips/kit |
| KT-929s | Fecal H. pylori Antigen Strip Test Kit | 50 strips/kit |
| KT-935s | Fecal C. difficile Antigen Strip Test Kit | 50 strips/kit |
| GASTROINTESTINAL DISEASE-Cassette Test Kits | ||
| KT-111 | FOB Cassette Test Kit | 20 tests/kit |
| KT-112 | Calprotectin Cassette Test Kit | 20 tests/kit |
| KT-113 | H. pylori Cassette Test Kit | 20 tests/kit |
| INFECTIOUS DISEASE | ||
| KT-851 | Varicella Zoster Virus (VZV) IgG ELISA Kit | 96 tests/kit |
| KT-867 | HAV IgG ELISA Kit | 96 tests/kit |
| KT-868 | HAV IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-869 | Total HAV Antibody ELISA Kit | 96 tests/kit |
| KT-897 | Zika Virus IgG ELISA Kit | 96 tests/kit |
| KT-898 | Zika Virus IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-1011 | HBeAg ELISA Kit | 96 tests/kit |
| KT-1015 | H. pylori IgG ELISA Kit | 96 tests/kit |
| KT-1018 | HEV IgG ELISA Kit | 96 tests/kit |
| KT-1019 | HEV IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KTR-1020 | Toxoplasma gondii IgG ELISA Kit | 96 tests/kit |
| KTR-1021 | Toxoplasma gondii IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KTR-1022 | Rubella IgG ELISA Kit | 96 tests/kit |
| KTR-1023 | Rubella IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KTR-1024 | Cytomegalovirus (CMV) IgG ELISA Kit | 96 tests/kit |
| KTR-1025 | Cytomegalovirus (CMV) IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-1026 | HSV 1+2 IgG ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-1027 | HSV 1+2 IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-1028 | HSV-1 IgG ELISA Kit | 96 tests/kit |
| KT-1029 | HSV-1 IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-1030 | HSV-2-IgG ELISA Kit | 96 tests/kit |
| KT-1031 | HSV-2 IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-1032 | Coronavirus COVID-19 IgG ELISA Kit - qualitative, N protein target, CE marked | 96 tests/kit |
| KT-1033 | Coronavirus COVID-19 IgM ELISA Kit - qualitative, N protein target, CE marked | 96 tests/kit |
| KT-1034 | COVID-19 Nucleocapsid IgG Quantitative ELISA Kit - CE marked | 96 tests/kit |
| KTR-1035 | Quantitative SARS-CoV-2 Spike Protein IgG ELISA - CE marked | 96 tests/kit |
| KTR-1036 | Quantitative SARS-CoV-2 Neutralizing Antibody ELISA - CE marked | 96 tests/kit |
| CARDIOVASCULAR DISEASE | ||
| KT-800 | Human Fetuin-A ELISA Kit | 96 tests/kit |
| KT-900 | High Sensitive Human Fetuin-A ELISA Kit | 96 tests/kit |
| KT-883 | Human Plasma NGAL ELISA Kit | 96 tests/kit |
| KT-885 | Plasma Calprotectin ELISA Kit | 96 tests/kit |
| KT-890 | Quantitative Serum/Plasma Myeloperoxidase ELISA Kit | 96 tests/kit |
| CALCIUM/BONE METABOLISM | ||
| KT-809 | Human Osteocalcin (1-43/49) ELISA Kit | 96 tests/kit |
| KT-715 | Total 25-OH Vitamin D EIA Kit (Two wash steps) | 96 tests/kit |
| KT-815 | Total 25-OH Vitamin D EIA Kit (Three wash steps) | 96 tests/kit |
| KT-888 | Human Intact PTH ELISA Kit | 96 tests/kit |
| KT-896 | Human VDBP ELISA Kit | 96 tests/kit |
| KT-819 | Human Growth Hormone ELISA Kit | 96 tests/kit |
| KT-840 | Human Anti-CaSR IgG ELISA Kit | 96 tests/kit |
| ENDOCRINOLOGY/DIABETES | ||
| KT-804 | Human Anti-Müllerian Hormone ELISA Kit | 96 tests/kit |
| KT-809 | Human Osteocalcin (1-43/49) ELISA Kit | 96 tests/kit |
| KT-819 | Human Growth Hormone ELISA Kit | 96 tests/kit |
| KT-871 | Active GLP-1 (7-36) ELISA Kit | 96 tests/kit |
| KT-876 | Total GLP-1 ELISA Kit | 96 tests/kit |
| KT-602 | Total GLP-1 ELISA Kit | 96 tests/kit |
| KT-910 | GLP-1 Sample Solid Phase Extraction Kit | 50 columns/kit |
| KTR-873 | Human FGF-21 N-terminal specific ELISA Kit | 96 tests/kit |
| KTR-874 | Human FGF-21 C-terminal specific ELISA Kit | 96 tests/kit |
| KT-879 | Human Intact FGF-21 ELISA Kit | 96 tests/kit |
| KT-886 | Human Insulin ELISA Kit | 96 tests/kit |
| KT-887 | Human High Sensitive Insulin ELISA Kit | 96 tests/kit |
| KTR-888 | Human Intact PTH ELISA Kit | 96 tests/kit |
| KT-881 | Human C-peptide ELISA Kit | 96 tests/kit |
| KT-882 | Human ACTH ELISA Kit | 96 tests/kit |
| KT-891 | Human High Sensitive C-peptide ELISA Kit | 96 tests/kit |
| AUTOIMMUNE DISEASE | ||
| KT-802 | Human Anti-FcεRIα Autoantibody ELISA Kit | 96 tests/kit |
| KT-803 | Human Anti-IgE Autoantibody ELISA Kit | 96 tests/kit |
| KT-830 | Human Anti-Gliadin IgA EIA Kit | 96 tests/kit |
| KT-831 | Human Anti-Gliadin IgG EIA Kit | 96 tests/kit |
| KT-832 | Human Anti-Tg IgG ELISA Kit | 96 tests/kit |
| KT-833 | Human Anti-TPO IgG ELISA Kit | 96 tests/kit |
| KT-840 | Human Anti-CaSR IgG ELISA Kit | 96 tests/kit |
| MISCELLANEOUS KITS | ||
| KT-805 | HAMA (Human Anti-Mouse Antibody) ELISA Kit | 96 tests/kit |
| KT-806 | HAHA (Human Anti-Human Antibody) ELISA Kit | 96 tests/kit |
| KT-807 | MAHA (Mouse Anti-Human Antibody) ELISA Kit | 96 tests/kit |
| KT-751 | Haptoglobin Immunoturbidimetric Assay | Inquire |
<
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://bellbrook.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Epitope Diagnostics全系列抗体及试剂盒产品"> 艾美捷科技代理Epitope Diagnostics全系列抗体及试剂盒产品
艾美捷科技特约代理美国Fitzgerald公司产品。
美国Fitzgerald Industries International, Inc.(简称FII公司),专门供应研究和生产体外诊断试剂用原料,产品超过9000多种,主要产品有:
(1)免疫比浊法用特种蛋白抗体:ApoAI, ApoB, IgG, IgA, IgM, C3, C4, TRF, CRP, Lp(a), PA, Albumin, β2-Microglobulin, etc;
(2)化学发光免疫测定法(CLIA)、酶联免疫测定法(EIA)、放射免疫测定法(RIA)、荧光免疫法(FIA)测定用各类高纯单克隆、多克隆抗体,纯化抗原;
(3)癌症系列抗原和抗体,如CA50, CEA, CA, AFP, CA 125, CA15-3, CA19-9, CA72-4, etc;
(4)配对抗体和抗原,如性腺,甲状腺系列等。
Fitzgerald is a manufacturer and supplier of primary antibodies, secondary antibodies, recombinant and native proteins, ELISA kits, Serum and Plasma, and many other biological reagents. Our motto ‘Bringing Life to Science’ illustrates our personal approach to addressing the individual needs, interests and expertise of our customers. We believe that our outstanding customer service and excellent quality products at competitive prices are key to our success.
Fitzgerald的主要产品类型包括:
(1)PRIMARY ANTIBODIES
Monoclonal Antibodies (8795)
Conjugated Monoclonal Antibodies (1329)
Purified Polyclonal Antibodies (28322)
Polyclonal Antibodies (3331)
Conjugated Polyclonal Antibodies (1551)
Antibody Matched Pairs (516)
(2)SECONDARY ANTIBODIES
Unconjugated Secondary Antibodies (179)
Purified Secondary Antibodies (235)
Conjugated Secondary Antibodies (1209)
(3)PROTEINS
Recombinant Proteins (2179)
Conjugated Proteins (3031)
Hapten Conjugates (474)
Complements (22)
Blocking Peptides (10052)
Native Proteins (773)
(4)IMMUNOGLOBULINS
Purified Immunoglobulins (171)
Conjugated Immunoglobulins (114)
(5)BIOLOGICAL REAGENTS
Poly-HRP Products (53)
Enzymes (106)
Colloidal Gold & Silver Products (37)
Diluents (40)
Chemical Reference (123)
Surfactants (4)
Substrates (12)
IHC Reagents (54)
Mounting Media & Preservatives (5)
Controls & Calibrators (50)
Isotype Controls (61)
(6)RESEARCH KITS
(7)SERUM, PLASMA & BLOOD
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://bellbrook.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Fitzgerald"> Fitzgerald
艾美捷科技代理Epitope Diagnostics全系列抗体及试剂盒产品。
Epitope Diagnostics是一家经过ISO 13845认证的医疗器械制造公司,位于圣地亚哥的索伦托谷生物技术中心。Epitope专门从事全球医疗设备和诊断行业的分析开发和制造。公司涉足领域包括胃肠道,心血管,感染和自身免疫性疾病,以及肿瘤/癌症和钙/骨代谢。Epitope Diagnostics Inc. (EDI) strives to develop, manufacture, and market the highest quality and most innovated in-vitro diagnostics (IVD) products to the global research, pharmaceutical, and healthcare community. We seek to become a major contributor in resolving the unmet medical needs of the world.
Epitope Diagnostics公司的主要产品包括:
| ANTIBODIES | ||
| MAB30699 | Anti-MMAE Monoclonal Antibody | |
| MAB30699b | Biotinylated Anti-MMAE Monoclonal Antibody | |
| MAB30700 | Anti-MMAF Monoclonal Antibody | |
| MAB30700b | Biotinylated Anti-MMAF Monoclonal Antibody | |
| 30698 | Anti-DM1 Polyclonal Antibody | |
| 30699 | Anti-MMAE Polyclonal Antibody | |
| 30700 | Anti-MMAE Polyclonal Antibody | |
| 30618 | Anti-Human FGF-21 N-terminal Specific Antibody, Affinity Purified | |
| 30661 | Anti-Human FGF-21 C-terminal Specific Antibody, Affinitiy Purified | |
| 30704 | Anti-Human Chromogranin A Monoclonal Antibody, Murine | |
| 30705 | Anti-Human Chromogranin A Polyclonal Antibody, Sheep | |
| 30706 | Anti-Human Chromogranin A N-terminal Polyclonal Antibody, Rabbit | |
| 30713 | Anti-Human Chromogranin A N/mid-regional Polyclonal Antibody, Rabbit | |
| 30714 | Anti-Human Chromogranin A C/mid-regional Polyclonal Antibody, Rabbit | |
| 30715 | Anti-Human Chromogranin A C-terminal Polyclonal Antibody, Rabbit | |
| 30657 | Anti-Human NGAL Polyclonal Antibody (IgG), Sheep | |
| 30658 | Anti-Human NGAL Polyclonal Antibody, Sheep, Affinity Purified | |
| TUMOR MARKERS & CANCER RESEARCH | ||
| KT-810 | Human Pepsinogen I ELISA Kit | 96 tests/kit |
| KT-811 | Human Pepsinogen II ELISA Kit | 96 tests/kit |
| KT-812 | Human Chromogranin A ELISA Kit (1st generation) | 96 tests/kit |
| KT-820 | Human Chromogranin A ELISA Kit (2nd generation) | 96 tests/kit |
| KT-855 | Human Chromogranin A ELISA Kit (2nd generation, wide range) | 96 tests/kit |
| KT-817 | Human Neuron Specific Enolase ELISA Kit | 96 tests/kit |
| KT-850 | q-FOB™ Quantitative Fecal Occult Blood Test ELISA Kit | 96 tests/kit |
| 30210 | Fecal Sample Collection Device for q-FOB™ | 50 tubes/kit |
| KT-111 | FOB Cassette Test Kit | 20 tests/kit |
| KT-705 | Intact Brentuximab Vedotin ELISA KIt | 96 tests/kit |
| KT-706 | Trastuzumab Emtansine EIA Kit | 96 tests/kit |
| KTR-755 | Humanized Anti-Her2/neu (Herceptin/trastuzumab) ELISA Kit | 96 tests/kit |
| KTR-756 | DM1 ADC EIA Kit | 96 tests/kit |
| KTR-757 | MMAE ADC EIA Kit | 96 tests/kit |
| KTR-758 | MMAF ADC EIA Kit | 96 tests/kit |
| KTR-782 | Intact MMAE ADC ELISA Kit | 96 tests/kit |
| KTR-783 | Intact MMAF ADC ELISA Kit | 96 tests/kit |
| GASTROINTESTINAL DISEASE-Serum ELISA Kits | ||
| KT-810 | Human Pepsinogen I ELISA Kit | 96 tests/kit |
| KT-811 | Human Pepsinogen II ELISA Kit | 96 tests/kit |
| KT-830 | Human Anti-Gliadin IgA EIA Kit | 96 tests/kit |
| KT-831 | Human Anti-Gliadin IgG EIA Kit | 96 tests/kit |
| KT-845 | Human Anti-Giardia lamblia IgA ELISA Kit | 96 tests/kit |
| KT-846 | Human Anti-Giardia lamblia IgG ELISA Kit | 96 tests/kit |
| KT-847 | Human Anti-Giardia lamblia IgM ELISA Kit | 96 tests/kit |
| GASTROINTESTINAL DISEASE-Fecal ELISA Kits | ||
| KT-824 | Qualitative Fecal H. pylori Antigen ELISA Kit | 96 tests/kit |
| KT-826 | Quantitative Fecal H. pylori Antigen ELISA Kit | 96 tests/kit |
| KT-828 | Fecal C. difficile GDH ELISA Kit | 96 tests/kit |
| KT-834 | Fecal C. difficile Toxin A ELISA Kit | 96 tests/kit |
| KT-835 | Fecal C. difficile Toxin B ELISA Kit | 96 tests/kit |
| KT-836 | Fecal C. difficile Toxin A & B ELISA Kit | 96 tests/kit |
| KT-837 | Fecal E. coli 0157 ELISA Kit | 96 tests/kit |
| KT-838 | Fecal Giardia lamblia Antigen ELISA Kit | 96 tests/kit |
| KT-839 | Fecal Cryptosporidium parvum Antigen ELISA Kit | 96 tests/kit |
| KT-841 | Fecal Rotavirus Antigen ELISA Kit | 96 tests/kit |
| KT-842 | Fecal Adenovirus Antigen ELISA Kit | 96 tests/kit |
| KT-849 | Quantitative Fecal Calprotectin ELISA Kit | 96 tests/kit |
| KT-850 | q-FOB™ Quantitative Fecal Occult Blood Test ELISA Kit | 96 tests/kit |
| KT-853 | Quantitative Fecal NGAL ELISA Kit | 96 tests/kit |
| KT-880 | Quantitative Fecal/Urine Myeloperoxidase ELISA Kit | 96 tests/kit |
| GASTROINTESTINAL DISEASE-Fecal Sample Collection Kits | ||
| KT-854 | Fecal H. pylori Sample Collection Kit | 50 tubes/kit |
| KT-864 | Fecal H. pylori/GDH/Toxin A&B Sample Collection Kit | 48 tubes/kit |
| KT-843 | Fecal Calprotectin Sample Collection Kit | 50 tubes/kit |
| 30210 | q-FOB™ Fecal Sample Collection Device | 50 tubes/kit |
| KT-844 | Fecal MPO Sample Collection Kit | 48 tubes/kit |
| KT-884 | Fecal NGAL Sample Collection Kit | 48 tubes/kit |
| FPC200 | Fecal Ova/Parasite Concentration Kit | 50 tubes/kit |
| GASTROINTESTINAL DISEASE-Rapid Tests | ||
| KT-313 | EpiTuub® Immunochemical Fecal Occult Blood Rapid Test Kit | 30 tests/kit |
| KT-917 | EpiTuub® Fecal Rotavirus Antigen Rapid Test Kit | 30 tests/kit |
| KT-918 | EpiTuub® Fecal Adenovirus Antigen Rapid Test Kit | 30 tests/kit |
| KT-920 | EpiTuub® Fecal Calprotectin Rapid Test Kit | 30 tests/kit |
| KT-921 | EpiTuub® Fecal Calprotectin Rapid Test Kit | 10 tests/kit |
| KT-922 | EpiTuub® Calprotectin/i-FOB DUO Test | 30 tests/kit |
| KT-926 | EpiTuub® Fecal Rota-Adeno Duo Antigen Rapid Test Kit | 30 tests/kit |
| KT-927 | EpiTuub® Fecal Giardia lamblia Antigen Rapid Test Kit | 30 tests/kit |
| KT-928 | EpiTuub® Fecal Cryptosporidiun parvum Antigen Rapid Test Kit | 30 tests/kit |
| KT-929 | EpiTuub® Fecal H. pylori Antigen Rapid Test Kit | 30 tests/kit |
| KT-935 | EpiTuub® Fecal C. difficile Antigen Rapid Test Kit | 30 tests/kit |
| GASTROINTESTINAL DISEASE-Strip Test Kit | ||
| KT-313s | Immunochemical Fecal Occult Blood Strip Test Kit | 50 strips/kit |
| KT-917s | Fecal Rotavirus Antigen Strip Test Kit | 50 strips/kit |
| KT-918s | Fecal Adenovirus Antigen Strip Test Kit | 50 strips/kit |
| KT-920s | Fecal Calprotectin Strip Test Kit | 50 strips/kit |
| KT-927s | Fecal Giardia lamblia Antigen Strip Test Kit | 50 strips/kit |
| KT-928s | Fecal Cryptosporidium parvum Antigen Strip Test Kit | 50 strips/kit |
| KT-929s | Fecal H. pylori Antigen Strip Test Kit | 50 strips/kit |
| KT-935s | Fecal C. difficile Antigen Strip Test Kit | 50 strips/kit |
| GASTROINTESTINAL DISEASE-Cassette Test Kits | ||
| KT-111 | FOB Cassette Test Kit | 20 tests/kit |
| KT-112 | Calprotectin Cassette Test Kit | 20 tests/kit |
| KT-113 | H. pylori Cassette Test Kit | 20 tests/kit |
| INFECTIOUS DISEASE | ||
| KT-851 | Varicella Zoster Virus (VZV) IgG ELISA Kit | 96 tests/kit |
| KT-867 | HAV IgG ELISA Kit | 96 tests/kit |
| KT-868 | HAV IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-869 | Total HAV Antibody ELISA Kit | 96 tests/kit |
| KT-897 | Zika Virus IgG ELISA Kit | 96 tests/kit |
| KT-898 | Zika Virus IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-1011 | HBeAg ELISA Kit | 96 tests/kit |
| KT-1015 | H. pylori IgG ELISA Kit | 96 tests/kit |
| KT-1018 | HEV IgG ELISA Kit | 96 tests/kit |
| KT-1019 | HEV IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KTR-1020 | Toxoplasma gondii IgG ELISA Kit | 96 tests/kit |
| KTR-1021 | Toxoplasma gondii IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KTR-1022 | Rubella IgG ELISA Kit | 96 tests/kit |
| KTR-1023 | Rubella IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KTR-1024 | Cytomegalovirus (CMV) IgG ELISA Kit | 96 tests/kit |
| KTR-1025 | Cytomegalovirus (CMV) IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-1026 | HSV 1+2 IgG ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-1027 | HSV 1+2 IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-1028 | HSV-1 IgG ELISA Kit | 96 tests/kit |
| KT-1029 | HSV-1 IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-1030 | HSV-2-IgG ELISA Kit | 96 tests/kit |
| KT-1031 | HSV-2 IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-1032 | Coronavirus COVID-19 IgG ELISA Kit - qualitative, N protein target, CE marked | 96 tests/kit |
| KT-1033 | Coronavirus COVID-19 IgM ELISA Kit - qualitative, N protein target, CE marked | 96 tests/kit |
| KT-1034 | COVID-19 Nucleocapsid IgG Quantitative ELISA Kit - CE marked | 96 tests/kit |
| KTR-1035 | Quantitative SARS-CoV-2 Spike Protein IgG ELISA - CE marked | 96 tests/kit |
| KTR-1036 | Quantitative SARS-CoV-2 Neutralizing Antibody ELISA - CE marked | 96 tests/kit |
| CARDIOVASCULAR DISEASE | ||
| KT-800 | Human Fetuin-A ELISA Kit | 96 tests/kit |
| KT-900 | High Sensitive Human Fetuin-A ELISA Kit | 96 tests/kit |
| KT-883 | Human Plasma NGAL ELISA Kit | 96 tests/kit |
| KT-885 | Plasma Calprotectin ELISA Kit | 96 tests/kit |
| KT-890 | Quantitative Serum/Plasma Myeloperoxidase ELISA Kit | 96 tests/kit |
| CALCIUM/BONE METABOLISM | ||
| KT-809 | Human Osteocalcin (1-43/49) ELISA Kit | 96 tests/kit |
| KT-715 | Total 25-OH Vitamin D EIA Kit (Two wash steps) | 96 tests/kit |
| KT-815 | Total 25-OH Vitamin D EIA Kit (Three wash steps) | 96 tests/kit |
| KT-888 | Human Intact PTH ELISA Kit | 96 tests/kit |
| KT-896 | Human VDBP ELISA Kit | 96 tests/kit |
| KT-819 | Human Growth Hormone ELISA Kit | 96 tests/kit |
| KT-840 | Human Anti-CaSR IgG ELISA Kit | 96 tests/kit |
| ENDOCRINOLOGY/DIABETES | ||
| KT-804 | Human Anti-Müllerian Hormone ELISA Kit | 96 tests/kit |
| KT-809 | Human Osteocalcin (1-43/49) ELISA Kit | 96 tests/kit |
| KT-819 | Human Growth Hormone ELISA Kit | 96 tests/kit |
| KT-871 | Active GLP-1 (7-36) ELISA Kit | 96 tests/kit |
| KT-876 | Total GLP-1 ELISA Kit | 96 tests/kit |
| KT-602 | Total GLP-1 ELISA Kit | 96 tests/kit |
| KT-910 | GLP-1 Sample Solid Phase Extraction Kit | 50 columns/kit |
| KTR-873 | Human FGF-21 N-terminal specific ELISA Kit | 96 tests/kit |
| KTR-874 | Human FGF-21 C-terminal specific ELISA Kit | 96 tests/kit |
| KT-879 | Human Intact FGF-21 ELISA Kit | 96 tests/kit |
| KT-886 | Human Insulin ELISA Kit | 96 tests/kit |
| KT-887 | Human High Sensitive Insulin ELISA Kit | 96 tests/kit |
| KTR-888 | Human Intact PTH ELISA Kit | 96 tests/kit |
| KT-881 | Human C-peptide ELISA Kit | 96 tests/kit |
| KT-882 | Human ACTH ELISA Kit | 96 tests/kit |
| KT-891 | Human High Sensitive C-peptide ELISA Kit | 96 tests/kit |
| AUTOIMMUNE DISEASE | ||
| KT-802 | Human Anti-FcεRIα Autoantibody ELISA Kit | 96 tests/kit |
| KT-803 | Human Anti-IgE Autoantibody ELISA Kit | 96 tests/kit |
| KT-830 | Human Anti-Gliadin IgA EIA Kit | 96 tests/kit |
| KT-831 | Human Anti-Gliadin IgG EIA Kit | 96 tests/kit |
| KT-832 | Human Anti-Tg IgG ELISA Kit | 96 tests/kit |
| KT-833 | Human Anti-TPO IgG ELISA Kit | 96 tests/kit |
| KT-840 | Human Anti-CaSR IgG ELISA Kit | 96 tests/kit |
| MISCELLANEOUS KITS | ||
| KT-805 | HAMA (Human Anti-Mouse Antibody) ELISA Kit | 96 tests/kit |
| KT-806 | HAHA (Human Anti-Human Antibody) ELISA Kit | 96 tests/kit |
| KT-807 | MAHA (Mouse Anti-Human Antibody) ELISA Kit | 96 tests/kit |
| KT-751 | Haptoglobin Immunoturbidimetric Assay | Inquire |
<
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://bellbrook.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Epitope Diagnostics全系列抗体及试剂盒产品"> 艾美捷科技代理Epitope Diagnostics全系列抗体及试剂盒产品艾美捷科技授权代理Bioclone品牌全系列产品。
【快速入口】
丁香通:https://vicbio.biomart.cn/supply/c_cate-582257.htm
艾美捷科技商城:http://www.amyjet.com/Index/lists/catid/27/kid/74.html
【品牌介绍】

美国Bioclone Inc.公司成立已逾20年,其独特的“一步法”生物磁分离技术,已经在全球生物科学研究领域得到广泛应用,无论是大规模批量生产还是微量的生物样品处理,该技术都具有快速、简单、操作灵活的优势,目前是磁珠行业内先进技术的领跑者。我司代理Bioclone产品范围包括:负向磁珠、法医类试剂盒、蛋白纯化试剂、荧光磁珠、免疫磁珠、离子交换磁珠、反相磁珠及其他试剂盒等。
【一步法纯化平台】

【产品列表】
| 货号 | 中文名称 | 规格 | 价格(人民币) |
| FA101 | 1µm BcMag™ 氨基磁珠 150mg | 150mg | 4125 |
| FA102 | 1µm BcMag™ 氨基磁珠 300mg | 300mg | 7875 |
| FA103 | 5µm BcMag™ 氨基磁珠 150mg | 150mg | 4125 |
| FA104 | 5µm BcMag™ 氨基磁珠 300mg | 300mg | 7875 |
| FA105 | 1µm BcMag™ DADPA活化磁珠 150mg | 150mg | 4875 |
| FA106 | 2µm BcMag™ DADPA活化磁珠 300mg | 300mg | 9150 |
| FA107 | 5µm BcMag™ DADPA活化磁珠 150mg | 150mg | 4875 |
| FA108 | 5µm BcMag™ DADPA活化磁珠 300mg | 300mg | 9150 |
| FA113 | 1µm BcMag™ 长链氨基磁珠 150mg | 150mg | 4875 |
| FA114 | 1µm BcMag™ 长链氨基磁珠 300mg | 300mg | 9150 |
| FA115 | 5µm BcMag™ 长链氨基磁珠 150mg | 150mg | 4875 |
| FA116 | 5µm BcMag™ 长链氨基磁珠 300mg | 300mg | 9150 |
| FB101 | 1µm BcMag™ 羧基磁珠 150mg | 150mg | 4125 |
| FB102 | 1µm BcMag™ 羧基磁珠 300mg | 300mg | 7875 |
| FB103 | 5µm BcMag™ 羧基磁珠 150mg | 150mg | 4125 |
| FB104 | 5µm BcMag™ 羧基磁珠 300mg | 300mg | 7875 |
| FB105 | 1µm BcMag™ 长链羧基磁珠 150mg | 150mg | 4875 |
| FB106 | 1µm BcMag™ 长链羧基磁珠 300mg | 300mg | 9150 |
| FB107 | 5µm BcMag™ 长链羧基磁珠 150mg | 150mg | 4875 |
| FB108 | 5µm BcMag™ 长链羧基磁珠 300mg | 300mg | 9150 |
| FB113 | BcMag™ 羧基磁珠偶连试剂盒 | Kit | 4125 |
| FC101 | 1µm BcMag™ 环氧基活化磁珠 150mg | 150mg | 4125 |
| FC102 | 1µm BcMag™ 环氧基活化磁珠 300mg | 300mg | 7875 |
| FC103 | 5µm BcMag™ 环氧基活化磁珠 150mg | 150mg | 4125 |
| FC104 | 5µm BcMag™ 环氧基活化磁珠 300mg | 300mg | 7875 |
| FC105 | 1µm BcMag™ 长链环氧基活化磁珠 150mg | 150mg | 4875 |
| FC106 | 1µm BcMag™ 长链环氧基活化磁珠 300mg | 300mg | 9150 |
| FC107 | 5µm BcMag™ 长链环氧基活化磁珠 150mg | 150mg | 4875 |
| FC108 | 5µm BcMag™ 长链环氧基活化磁珠 300mg | 300mg | 9150 |
| FC109 | BcMag™ 环氧基活化磁珠偶连试剂盒 | Kit | 4125 |
| FD101 | 1µm BcMag™ 酰肼基磁珠 150mg | 150mg | 4125 |
| FD102 | 1µm BcMag™ 酰肼基磁珠 300mg | 300mg | 7875 |
| FD103 | 5µm BcMag™ 酰肼基磁珠 150mg | 150mg | 4125 |
| FD104 | 5µm BcMag™ 酰肼基磁珠 300mg | 300mg | 7875 |
| FD105 | BcMag™ 酰肼基磁珠偶连试剂盒 | Kit | 4125 |
| FD106 | BcMag™ 糖蛋白和抗体结合试剂盒,含1um酰肼磁珠 kit | kit | 5250 |
| FD107 | BcMag™ 糖蛋白和抗体结合试剂盒,含1um可洗脱式酰肼磁珠 kit | kit | 6750 |
| FE101 | 1µm BcMag™ 醛基磁珠 150mg | 150mg | 4125 |
| FE102 | 1µm BcMag™ 醛基磁珠 300mg | 300mg | 7875 |
| FE103 | 5µm BcMag™ 醛基磁珠 150mg | 150mg | 4125 |
| FE104 | 5µm BcMag™ 醛基磁珠 300mg | 300mg | 7875 |
| FE105 | 1µm BcMag™ 长链醛基磁珠 150mg | 150mg | 4875 |
| FE106 | 1µm BcMag™ 长链醛基磁珠 300mg | 300mg | 9150 |
| FE107 | 5µm BcMag™ 长链醛基磁珠 150mg | 150mg | 4875 |
| FE108 | 5µm BcMag™ 长链醛基磁珠 300mg | 300mg | 9150 |
| FE109 | BcMag™ 醛基磁珠偶连试剂盒 | Kit | 4125 |
| FF101 | 1µm BcMag™ 二氧化硅改良磁珠磁珠 150mg | 150mg | 3750 |
| FF102 | 1µm BcMag™ 二氧化硅改良磁珠磁珠 300mg | 300mg | 6750 |
| FF103 | 5µm BcMag™ 二氧化硅改良磁珠磁珠 150mg | 150mg | 3750 |
| FF104 | 5µm BcMag™ 二氧化硅改良磁珠磁珠 300mg | 300mg | 6750 |
| FF105 | 1µm BcMag™ IDA磁珠 5ml | 5ml | 4125 |
| FF106 | 1µm BcMag™ IDA磁珠 10ml | 10ml | 7875 |
| FF109 | 5µm BcMag™ IDA磁珠 150mg | 150mg | 4125 |
| FF110 | 5µm BcMag™ IDA磁珠 300mg | 300mg | 7875 |
| FG101 | 1µm BcMag™ 碘乙酰基活性磁珠 150mg | 150mg | 4125 |
| FG102 | 1µm BcMag™ 碘乙酰基活性磁珠 300mg | 300mg | 7875 |
| FG103 | 5µm BcMag™ 碘乙酰基活性磁珠 150mg | 150mg | 4125 |
| FG104 | 5µm BcMag™ 碘乙酰基活性磁珠 300mg | 300mg | 7875 |
| FG105 | 1µm BcMag™ 长链碘乙酰基活性磁珠 150mg | 150mg | 4875 |
| FG106 | 1µm BcMag™ 长链碘乙酰基活性磁珠 300mg | 300mg | 9150 |
| FG107 | 5µm BcMag™ 长链碘乙酰基活性磁珠 150mg | 150mg | 4875 |
| FG108 | 5µm BcMag™ 长链碘乙酰基活性磁珠 300mg | 300mg | 9150 |
| FG109 | BcMag™ 多肽偶联试剂盒,含1um碘乙酰基磁珠 Kit | Kit | 5250 |
| FG110 | BcMag™ 多肽偶联试剂盒,含1um可洗脱式碘乙酰基磁珠 Kit | Kit | 6750 |
| FG113 | BcMag™ 碘乙酰基磁珠偶连试剂盒 | Kit | 4125 |
| FH101 | 1µm BcMag™ DVS磁珠 150mg | 150mg | 4125 |
| FH102 | 1µm BcMag™ DVS磁珠 300mg | 300mg | 7875 |
| FH103 | 5µm BcMag™ DVS磁珠 150mg | 150mg | 4125 |
| FH104 | 5µm BcMag™ DVS磁珠 300mg | 300mg | 7875 |
| FI101 | 1µm BcMag™ NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 4125 |
| FI102 | 1µm BcMag™ NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 7875 |
| FI103 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 4125 |
| FI104 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 7875 |
| FI105 | 1µm BcMag™ 长链NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 4875 |
| FI106 | 1µm BcMag™ 长链NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 9150 |
| FI107 | 5µm BcMag™ 长链NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 4875 |
| FI108 | 5µm BcMag™ 长链NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 9150 |
| FI109 | BcMag™ NHS磁珠偶连试剂盒 | Kit | 4125 |
| FJ101 | 1µm BcMag™ 羟基磁珠 150mg | 150mg | 4125 |
| FJ102 | 1µm BcMag™ 羟基磁珠 300mg | 300mg | 7875 |
| FJ103 | 5µm BcMag™ 羟基磁珠 150mg | 150mg | 4125 |
| FJ104 | 5µm BcMag™ 羟基磁珠 300mg | 300mg | 7875 |
| FJ105 | 1µm BcMag™ 长链羟基磁珠 150mg | 150mg | 4875 |
| FJ106 | 1µm BcMag™ 长链羟基磁珠 300mg | 300mg | 9150 |
| FJ107 | 5µm BcMag™ 长链羟基磁珠 150mg | 150mg | 4875 |
| FJ108 | 5µm BcMag™ 长链羟基磁珠 300mg | 300mg | 9150 |
| FP101 | 1µm BcMag™ 巯基磁珠 150mg | 150mg | 4125 |
| FP102 | 1µm BcMag™ 巯基磁珠 300mg | 300mg | 7875 |
| FP103 | 5µm BcMag™ 巯基磁珠 150mg | 150mg | 4125 |
| FP104 | 5µm BcMag™ 巯基磁珠 300mg | 300mg | 7875 |
| FP105 | 1µm BcMag™ 长链巯基磁珠 150mg | 150mg | 4875 |
| FP106 | 1µm BcMag™ 长链巯基磁珠 300mg | 300mg | 9150 |
| FP107 | 5µm BcMag™ 长链巯基磁珠 150mg | 150mg | 4875 |
| FP108 | 5µm BcMag™ 长链巯基磁珠 300mg | 300mg | 9150 |
| FR101 | 1µm BcMag™ 对甲苯磺酰基磁珠 150mg | 150mg | 4125 |
| FR102 | 1µm BcMag™ 对甲苯磺酰基磁珠 300mg | 300mg | 7875 |
| FR103 | 5µm BcMag™ 对甲苯磺酰基磁珠 150mg | 150mg | 4125 |
| FR104 | 5µm BcMag™ 对甲苯磺酰基磁珠 300mg | 300mg | 7875 |
| FR105 | 1µm BcMag™ 长链对甲苯磺酰基磁珠 150mg | 150mg | 4875 |
| FR106 | 1µm BcMag™ 长链对甲苯磺酰基磁珠 300mg | 300mg | 9150 |
| FR107 | 5µm BcMag™ 长链对甲苯磺酰基磁珠 150mg | 150mg | 4875 |
| FR108 | 5µm BcMag™ 长链对甲苯磺酰基磁珠 300mg | 300mg | 9150 |
| FW101 | 1µm BcMag™ CDI磁珠 150mg | 150mg | 4125 |
| FW102 | 1µm BcMag™ CDI磁珠 300mg | 300mg | 7875 |
| FW103 | 5µm BcMag™ CDI磁珠 150mg | 150mg | 4125 |
| FW104 | 5µm BcMag™ CDI磁珠 300mg | 300mg | 7875 |
| FW111 | BcMag™ CDI磁珠偶连试剂盒 | Kit | 4125 |
| FX101 | 1µm BcMag™ 硫醇基磁珠 150mg | 150mg | 4125 |
| FX102 | 1µm BcMag™ 硫醇基磁珠 300mg | 300mg | 7875 |
| FX103 | 5µm BcMag™ 硫醇基磁珠 150mg | 150mg | 4125 |
| FX104 | 5µm BcMag™ 硫醇基磁珠 300mg | 300mg | 7875 |
| FX105 | 1µm BcMag™ 长链硫醇基磁珠 150mg | 150mg | 4875 |
| FX106 | 1µm BcMag™ 长链硫醇基磁珠 300mg | 300mg | 9150 |
| FX107 | 5µm BcMag™ 长链硫醇基磁珠 150mg | 150mg | 4875 |
| FX108 | 5µm BcMag™ 长链硫醇基磁珠 300mg | 300mg | 9150 |
| IL101 | 1µm BcMag™ 炔基磁珠 150mg | 150mg | 4125 |
| IL102 | 1µm BcMag™ 炔基磁珠 300mg | 300mg | 7875 |
| IL103 | 5µm BcMag™ 炔基磁珠 150mg | 150mg | 4125 |
| IL104 | 5µm BcMag™ 炔基磁珠 300mg | 300mg | 7875 |
| IM101 | 1µm BcMag™ 叠氮基活化磁珠 150mg | 150mg | 4125 |
| IM102 | 1µm BcMag™ 叠氮基活化磁珠 300mg | 300mg | 7875 |
| IM103 | 5µm BcMag™ 叠氮基活化磁珠 150mg | 150mg | 4125 |
| IM104 | 5µm BcMag™ 叠氮基活化磁珠 300mg | 300mg | 7875 |
| IA101 | 1µm BcMag™ 可洗脱式氨基磁珠 150mg | 150mg | 5625 |
| IA102 | 1µm BcMag™ 可洗脱式氨基磁珠 300mg | 300mg | 9750 |
| IA103 | 2.5µm BcMag™ 可洗脱式氨基磁珠 150mg | 150mg | 5625 |
| IA104 | 2.5µm BcMag™ 可洗脱式氨基磁珠 300mg | 300mg | 9750 |
| IB101 | 1µm BcMag™ 可洗脱式羧基磁珠 150mg | 150mg | 5625 |
| IB102 | 1µm BcMag™ 可洗脱式羧基磁珠 300mg | 300mg | 9750 |
| IB103 | 2.5µm BcMag™ 可洗脱式羧基磁珠 150mg | 150mg | 5625 |
| IB104 | 2.5µm BcMag™ 可洗脱式羧基磁珠 300mg | 300mg | 9750 |
| IC101 | 1µm BcMag™ 可洗脱式环氧基活化磁珠 150mg | 150mg | 5625 |
| IC102 | 1µm BcMag™ 可洗脱式环氧基活化磁珠 300mg | 300mg | 9750 |
| IC103 | 2.5µm BcMag™ 可洗脱式环氧基活化磁珠 150mg | 150mg | 5625 |
| IC104 | 2.5µm BcMag™ 可洗脱式环氧基活化磁珠 300mg | 300mg | 9750 |
| ID101 | 1µm BcMag™ 可洗脱式酰肼基磁珠 150mg | 150mg | 5625 |
| ID102 | 1µm BcMag™ 可洗脱式酰肼基磁珠 300mg | 300mg | 9750 |
| ID103 | 2.5µm BcMag™ 可洗脱式酰肼基磁珠 150mg | 150mg | 5625 |
| ID104 | 2.5µm BcMag™ 可洗脱式酰肼基磁珠 300mg | 300mg | 9750 |
| IE101 | 1µm BcMag™ 可洗脱式醛基磁珠 150mg | 150mg | 5625 |
| IE102 | 1µm BcMag™ 可洗脱式醛基磁珠 300mg | 300mg | 9750 |
| IE103 | 2.5µm BcMag™ 可洗脱式醛基磁珠 150mg | 150mg | 5625 |
| IE104 | 2.5µm BcMag™ 可洗脱式醛基磁珠 300mg | 300mg | 9750 |
| IG101 | 1µm BcMag™ 可洗脱式碘乙酰基活性磁珠 150mg | 150mg | 5625 |
| IG102 | 1µm BcMag™ 可洗脱式碘乙酰基活性磁珠 300mg | 300mg | 9750 |
| IG103 | 2.5µm BcMag™ 可洗脱式碘乙酰基活性磁珠 150mg | 150mg | 5625 |
| IG104 | 2.5µm BcMag™ 可洗脱式碘乙酰基活性磁珠 300mg | 300mg | 9750 |
| II101 | 1µm BcMag™ 可洗脱式NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 5625 |
| II102 | 1µm BcMag™ 可洗脱式NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 9750 |
| II103 | 2.5µm BcMag™ 可洗脱式NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 5625 |
| II104 | 2.5µm BcMag™ 可洗脱式NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 9750 |
| IJ101 | 1µm BcMag™ 可洗脱式叠氮基活化磁珠 150mg | 150mg | 5625 |
| IJ102 | 1µm BcMag™ 可洗脱式叠氮基活化磁珠 300mg | 300mg | 9750 |
| IJ103 | 2.5µm BcMag™ 可洗脱式叠氮基活化磁珠 150mg | 150mg | 5625 |
| IJ104 | 2.5µm BcMag™ 可洗脱式叠氮基活化磁珠 300mg | 300mg | 9750 |
| IK101 | 1µm BcMag™ 可洗脱式 炔基磁珠 150mg | 150mg | 5625 |
| IK102 | 1µm BcMag™ 可洗脱式 炔基磁珠 300mg | 300mg | 9750 |
| IK103 | 2.5µm BcMag™ 可洗脱式 炔基磁珠 150mg | 150mg | 5625 |
| IK104 | 2.5µm BcMag™ 可洗脱式 炔基磁珠 300mg | 300mg | 9750 |
| IR101 | 1µm BcMag™ 可洗脱式 对甲苯磺酰基磁珠 150mg | 150mg | 5625 |
| IR102 | 1µm BcMag™ 可洗脱式对甲苯磺酰基磁珠 300mg | 300mg | 9750 |
| IR103 | 2.5µm BcMag™ 可洗脱式对甲苯磺酰基磁珠 150mg | 150mg | 5625 |
| IR104 | 2.5µm BcMag™ 可洗脱式对甲苯磺酰基磁珠 300mg | 300mg | 9750 |
| AA101 | BcMag™ 一步法哺乳动物细胞DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AA102 | BcMag™ 一步法哺乳动物细胞DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AE101 | BcMag™ 一步法细菌DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AE102 | BcMag™ 一步法细菌DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AF101 | BcMag™ 一步法血液DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AF102 | BcMag™ 一步法血液DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AG101 | BcMag™ 一步法口腔细胞DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AG102 | BcMag™ 一步法口腔细胞DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AH101 | BcMag™ 一步法DNA/RNA纯化试剂盒 1ml | 1ml | 2250 |
| AH102 | BcMag™ 一步法DNA/RNA纯化试剂盒 5ml | 5ml | 6750 |
| AI101 | BcMag™ 一步法一代测序纯化试剂盒 1ml | 1ml | 2250 |
| AI102 | BcMag™ 一步法一代测序纯化试剂盒 5ml | 5ml | 6750 |
| AJ101 | BcMag™ One-Step FFPE & FNA DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AJ102 | BcMag™ One-Step FFPE & FNA DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AK101 | BcMag™ 一步法荧光标记物清除试剂盒 1ml | 1ml | 2250 |
| AK102 | BcMag™ 一步法荧光标记物清除试剂盒 5ml | 5ml | 10350 |
| AL101 | BcMag™ 一步法真菌和酵母DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AL102 | BcMag™ 一步法真菌和酵母DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AM101 | BcMag™ 一步法昆虫DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AM102 | BcMag™ 一步法昆虫DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AN101 | BcMag™ 一步法鼠尾DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AN102 | BcMag™ 一步法鼠尾DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AO101 | BcMag™ 一步法NGS纯化试剂盒 1ml | 1ml | 2250 |
| AO102 | BcMag™ 一步法NGS纯化试剂盒 5ml | 5ml | 10350 |
| AP101 | BcMag™ 一步法PCR纯化试剂盒 1ml | 1ml | 2250 |
| AP102 | BcMag™ 一步法PCR纯化试剂盒 5ml | 5ml | 10350 |
| AQ101 | BcMag™ 一步法植物DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AQ102 | BcMag™ 一步法植物DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AR101 | BcMag™ 一步法唾液病毒RNA-DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AR102 | BcMag™ 一步法唾液病毒RNA-DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AU101 | BcMag™ 一步法RNA清除试剂盒 1ml | 1ml | 2250 |
| AU102 | BcMag™ 一步法RNA清除试剂盒 3ml | 3ml | 5250 |
| AV101 | BcMag™ 一步法DNA/RNA清除试剂盒 1ml | 1ml | 2250 |
| AV102 | BcMag™ 一步法DNA/RNA清除试剂盒 3ml | 3ml | 5250 |
| AW101 | BcMag™ 一步法单链DNA清除试剂盒 1ml | 1ml | 2250 |
| AW102 | BcMag™ 一步法单链DNA清除试剂盒 3ml | 3ml | 5250 |
| AB101 | BcMag™ 骨骼DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AB102 | BcMag™ 骨骼DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AC101 | BcMag™ 游离DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AC102 | BcMag™ 游离DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AD101 | BcMag™ 发干DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AD102 | BcMag™ 发干DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AF101 | BcMag™ 一步法血液DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AF102 | BcMag™ 一步法血液DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AS101 | BcMag™ 一步法脱落细胞DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AS102 | BcMag™ 一步法脱落细胞DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AT101 | BcMag™ 精斑DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AT102 | BcMag™ 精斑DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AX101 | BcMag™ 一步法PCR抑制剂清除试剂盒 1ml | 1ml | 2250 |
| AX102 | BcMag™ 一步法PCR抑制剂清除试剂盒 5ml | 5ml | 10350 |
| AZ101 | BcMag™ 一步法指纹DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AZ102 | BcMag™ 一步法指纹DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AAA101 | BcMag™ 一步法头皮屑DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AAA102 | BcMag™ 一步法头皮屑DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| MG101 | BcMag™ GST-标签蛋白纯化试剂盒 Kit | Kit | 4425 |
| MG102 | BcMag™ GST-标签蛋白纯化试剂盒 5ml | 5ml | 5925 |
| MG103 | BcMag™ GST-标签蛋白纯化试剂盒 10ml | 10ml | 8250 |
| MHN101 | BcMag™ IDA-Ni His-标签蛋白纯化试剂盒 5ml | 5ml | 5250 |
| MHN102 | BcMag™ IDA-Ni His-标签蛋白纯化试剂盒 10ml | 10ml | 9000 |
| MHN103 | BcMag™ IDA-Ni His-标签蛋白纯化试剂盒 50ml | 50ml | 37500 |
| MHO101 | BcMag™ IDA-Co His-标签蛋白纯化试剂盒 5ml | 5ml | 5250 |
| MHO102 | BcMag™ IDA-Co His-标签蛋白纯化试剂盒 10ml | 10ml | 9000 |
| MHO103 | BcMag™ IDA-Co His-标签蛋白纯化试剂盒 50ml | 50ml | 37500 |
| MHP101 | BcMag™ 分泌型His-标签蛋白纯化试剂盒 5ml | 5ml | 5250 |
| MHP102 | BcMag™ 分泌型His-标签蛋白纯化试剂盒 10ml | 10ml | 9000 |
| MHQ101 | BcMag™ 低表达量His-标签蛋白纯化试剂盒 5ml | 5ml | 5250 |
| MHQ102 | BcMag™ 低表达量His-标签蛋白纯化试剂盒 10ml | 10ml | 9000 |
| HA101 | 2.5µm BcMag™ 链霉亲和素铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HA102 | 2.5µm BcMag™ 链霉亲和素铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HA103 | 5µm BcMag™ 链霉亲和素铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HA104 | 5µm BcMag™ 链霉亲和素铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HB101 | 2.5µm BcMag™ 链霉亲和素铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HB102 | 2.5µm BcMag™ 链霉亲和素铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HB103 | 5µm BcMag™ 链霉亲和素铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HB104 | 5µm BcMag™ 链霉亲和素铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HC101 | 2.5µm BcMag™ 链霉亲和素钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HC102 | 2.5µm BcMag™ 链霉亲和素钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HC103 | 5µm BcMag™ 链霉亲和素钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HC104 | 5µm BcMag™ 链霉亲和素钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HD101 | 2.5µm BcMag™ 单体亲和素铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HD102 | 2.5µm BcMag™ 单体亲和素铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HD103 | 5µm BcMag™ 单体亲和素铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HD104 | 5µm BcMag™ 单体亲和素铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HE101 | 2.5µm BcMag™ 单体亲和素铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HE102 | 2.5µm BcMag™ 单体亲和素铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HE103 | 5µm BcMag™ 单体亲和素铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HE104 | 5µm BcMag™ 单体亲和素铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HF101 | 2.5µm BcMag™ 单体亲和素钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HF102 | 2.5µm BcMag™ 单体亲和素钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HF103 | 5µm BcMag™ 单体亲和素钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HF104 | 5µm BcMag™ 单体亲和素钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HG101 | 2.5µm BcMag™ 蛋白A/G铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HG102 | 2.5µm BcMag™ 蛋白A/G铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HG103 | 5µm BcMag™ 蛋白A/G铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HG104 | 5µm BcMag™ 蛋白A/G铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HH101 | 2.5µm BcMag™ 蛋白A/G铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HH102 | 2.5µm BcMag™ 蛋白A/G铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HH103 | 5µm BcMag™ 蛋白A/G铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HH104 | 5µm BcMag™ 蛋白A/G铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HI101 | 2.5µm BcMag™ 蛋白A/G钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HI102 | 2.5µm BcMag™ 蛋白A/G钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HI103 | 5µm BcMag™ 蛋白A/G钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HI104 | 5µm BcMag™ 蛋白A/G钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HJ101 | 2.5µm BcMag™ 蛋白A铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HJ102 | 2.5µm BcMag™ 蛋白A铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HJ103 | 5µm BcMag™ 蛋白A铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HJ104 | 5µm BcMag™ 蛋白A铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HK101 | 2.5µm BcMag™ 蛋白A铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HK102 | 2.5µm BcMag™ 蛋白A铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HK103 | 5µm BcMag™ 蛋白A铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HK104 | 5µm BcMag™ 蛋白A铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HL101 | 2.5µm BcMag™ 蛋白A钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HL102 | 2.5µm BcMag™ 蛋白A钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HL103 | 5µm BcMag™ 蛋白A钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HL104 | 5µm BcMag™ 蛋白A钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HM101 | 2.5µm BcMag™ 蛋白G铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HM102 | 2.5µm BcMag™ 蛋白G铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HM103 | 5µm BcMag™ 蛋白G铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HM104 | 5µm BcMag™ 蛋白G铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HN101 | 2.5µm BcMag™ 蛋白G铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HN102 | 2.5µm BcMag™ 蛋白G铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HN103 | 5µm BcMag™ 蛋白G铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HN104 | 5µm BcMag™ 蛋白G铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HO101 | 2.5µm BcMag™ 蛋白G钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HO102 | 2.5µm BcMag™ 蛋白G钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HO103 | 5µm BcMag™ 蛋白G钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HO104 | 5µm BcMag™ 蛋白G钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HP101 | 2.5µm BcMag™ 蛋白L铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HP102 | 2.5µm BcMag™ 蛋白L铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HP103 | 5µm BcMag™ 蛋白L铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HP104 | 5µm BcMag™ 蛋白L铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HQ101 | 2.5µm BcMag™ 蛋白L铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HQ102 | 2.5µm BcMag™ 蛋白L铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HQ103 | 5µm BcMag™ 蛋白 L铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HQ104 | 5µm BcMag™ 蛋白L铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HR101 | 2.5µm BcMag™ 蛋白L钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HR102 | 2.5µm BcMag™ 蛋白L钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HR103 | 5µm BcMag™ 蛋白L钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HR104 | 5µm BcMag™ 蛋白L钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| GA101 | 2.5µm BcMag™ 醛基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GA102 | 2.5µm BcMag™ 醛基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GA103 | 5µm BcMag™ 醛基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GA104 | 5µm BcMag™ 醛基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GB101 | 2.5µm BcMag™ 醛基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GB102 | 2.5µm BcMag™ 醛基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GB103 | 5µm BcMag™ 醛基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GB104 | 5µm BcMag™ 醛基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GC101 | 2.5µm BcMag™ 醛基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GC102 | 2.5µm BcMag™ 醛基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GC103 | 5µm BcMag™ 醛基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GC104 | 5µm BcMag™ 醛基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GD101 | 2.5µm BcMag™ 氨基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GD102 | 2.5µm BcMag™ 氨基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GD103 | 5µm BcMag™ 氨基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GD104 | 5µm BcMag™ 氨基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GE101 | 2.5µm BcMag™ 氨基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GE102 | 2.5µm BcMag™ 氨基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GE103 | 5µm BcMag™ 氨基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GE104 | 5µm BcMag™ 氨基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GF101 | 2.5µm BcMag™ 氨基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GF102 | 2.5µm BcMag™ 氨基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GF103 | 5µm BcMag™ 氨基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GF104 | 5µm BcMag™ 氨基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GG101 | 2.5µm BcMag™ 羧基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GG102 | 2.5µm BcMag™ 羧基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GG103 | 5µm BcMag™ 羧基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GG104 | 5µm BcMag™ 羧基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GH101 | 2.5µm BcMag™ 羧基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GH102 | 2.5µm BcMag™ 羧基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GH103 | 5µm BcMag™ 羧基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GH104 | 5µm BcMag™ 羧基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GI101 | 2.5µm BcMag™ 羧基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GI102 | 2.5µm BcMag™ 羧基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GI103 | 5µm BcMag™ 羧基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GI104 | 5µm BcMag™ 羧基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GJ101 | 2.5µm BcMag™ 酰肼基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GJ102 | 2.5µm BcMag™ 酰肼基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GJ103 | 5µm BcMag™ 酰肼基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GJ104 | 5µm BcMag™ 酰肼基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GK101 | 2.5µm BcMag™ 酰肼基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GK102 | 2.5µm BcMag™ 酰肼基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GK103 | 5µm BcMag™ 酰肼基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GK104 | 5µm BcMag™ 酰肼基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GL101 | 2.5µm BcMag™ 酰肼基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GL102 | 2.5µm BcMag™ 酰肼基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GL103 | 5µm BcMag™ 酰肼基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GL104 | 5µm BcMag™ 酰肼基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GM101 | 2.5µm BcMag™ 碘乙酰基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GM102 | 2.5µm BcMag™ 碘乙酰基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GM103 | 5µm BcMag™ 碘乙酰基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GM104 | 5µm BcMag™ 碘乙酰基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GN101 | 2.5µm BcMag™ 碘乙酰基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GN102 | 2.5µm BcMag™ 碘乙酰基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GN103 | 5µm BcMag™ 碘乙酰基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GN104 | 5µm BcMag™ 碘乙酰基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GO101 | 2.5µm BcMag™ 碘乙酰基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GO102 | 2.5µm BcMag™ 碘乙酰基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GO103 | 5µm BcMag™ 碘乙酰基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GO104 | 5µm BcMag™ 碘乙酰基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GP101 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铕荧光磁珠 15mg | 15mg | 3750 |
| GP102 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铕荧光磁珠 30mg | 30mg | 6750 |
| GP103 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铕荧光磁珠 15mg | 15mg | 3750 |
| GP104 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铕荧光磁珠 30mg | 30mg | 6750 |
| GQ101 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铽荧光磁珠 15mg | 15mg | 3750 |
| GQ102 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铽荧光磁珠 30mg | 30mg | 6750 |
| GQ103 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铽荧光磁珠 15mg | 15mg | 3750 |
| GQ104 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铽荧光磁珠 30mg | 30mg | 6750 |
| GR101 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端钌荧光磁珠 15mg | 15mg | 3750 |
| GR102 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端钌荧光磁珠 30mg | 30mg | 6750 |
| GR103 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端钌荧光磁珠 15mg | 15mg | 3750 |
| GR104 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端钌荧光磁珠 30mg | 30mg | 6750 |
| MA101 | BcMag™ 蛋白 A/G 纯化试剂盒 Kit | Kit | 5250 |
| MA102 | BcMag™ 蛋白 A/G 磁珠 5ml | 5ml | 5850 |
| MA103 | BcMag™ 蛋白 A/G 磁珠 10ml | 10ml | 9750 |
| MAA101 | BcMag™ 蛋白 A磁珠纯化试剂盒 3ml beads kit | 3ml beads kit | 5250 |
| MAA102 | BcMag™ 蛋白A磁珠 5ml | 5ml | 5850 |
| MAA103 | BcMag™ 蛋白A磁珠 10ml | 10ml | 9750 |
| MAG101 | BcMag™ 蛋白 G磁珠纯化试剂盒 3ml beads kit | 3ml beads kit | 5250 |
| MAG102 | BcMag™ 蛋白G磁珠 5ml | 5ml | 5850 |
| MAG103 | BcMag™ 蛋白G磁珠 10ml | 10ml | 9750 |
| MAL101 | BcMag™ 蛋白 L磁珠纯化试剂盒 3ml beads kit | 3ml beads kit | 5250 |
| MAL102 | BcMag™ 蛋白L磁珠 5ml | 5ml | 5850 |
| MAL103 | BcMag™ 蛋白L磁珠 10ml | 10ml | 9750 |
| EA101 | BcMag™ 快速抗体纯化试剂盒 2ml | 2ml | 2250 |
| EA102 | BcMag™ 快速抗体纯化试剂盒 10ml | 10ml | 8250 |
| EB101 | BcMag™ 一步法抗体纯化试剂盒 2ml | 2ml | 2250 |
| EB102 | BcMag™ 一步法抗体纯化试剂盒 10ml | 10ml | 8250 |
| EC101 | BcMag™ 硼酸亲和磁珠磁珠 250mg | 250mg | 5175 |
| EC102 | BcMag™ 硼酸亲和磁珠磁珠 500mg | 500mg | 9750 |
| MMI101 | BcMag™ 单体亲和素磁珠 Kit | Kit | 7275 |
| MMI102 | BcMag™ 单体亲和素磁珠 5ml | 5ml | 8250 |
| MMI103 | BcMag™ 单体亲和素磁珠 10ml | 10ml | 14250 |
| MMI105 | BcMag™ 链酶亲和素磁珠 5ml | 5ml | 5250 |
| MMI106 | BcMag™ 链酶亲和素磁珠 10ml | 10ml | 9750 |
| MMI107 | BcMag™ 可洗脱式链酶亲和素磁珠 2ml | 2ml | 3750 |
| MMI108 | BcMag™ 可洗脱式链酶亲和素磁珠 5ml | 5ml | 8250 |
| MMI109 | BcMag™ 可洗脱式链酶亲和素磁珠 10ml | 10ml | 13500 |
| FM101 | 1µm BcMag™ DEAE 磁珠 250mg | 250mg | 5175 |
| FM102 | 1µm BcMag™ DEAE 磁珠 500mg | 500mg | 9750 |
| FM103 | 5µm BcMag™ DEAE 磁珠 250mg | 250mg | 5175 |
| FM104 | 5µm BcMag™ DEAE 磁珠 500mg | 500mg | 9750 |
| FM105 | 1µm BcMag™ PSA 磁珠 250mg | 250mg | 5175 |
| FM106 | 1µm BcMag™ PSA 磁珠 500mg | 500mg | 9750 |
| FM107 | 5µm BcMag™ PSA 磁珠 250mg | 250mg | 5175 |
| FM108 | 5µm BcMag™ PSA磁珠 500mg | 500mg | 9750 |
| FN101 | 1µm BcMag™ WCX 磁珠 250mg | 250mg | 5175 |
| FN102 | 1µm BcMag™ WCX 磁珠 500mg | 500mg | 9750 |
| FN103 | 5µm BcMag™ WCX 磁珠 250mg | 250mg | 5175 |
| FN104 | 5µm BcMag™ WCX 磁珠 500mg | 500mg | 9750 |
| FU101 | 1µm BcMag™ SAX 磁珠 250mg | 250mg | 5175 |
| FU102 | 1µm BcMag™ SAX 磁珠 500mg | 500mg | 9750 |
| FU103 | 5µm BcMag™ SAX 磁珠 250mg | 250mg | 5175 |
| FU104 | 5µm BcMag™ SAX 磁珠 500mg | 500mg | 9750 |
| FV101 | 1µm BcMag™ SCX 磁珠 250mg | 250mg | 5175 |
| FV102 | 1µm BcMag™ SCX 磁珠 500mg | 500mg | 9750 |
| FV103 | 5µm BcMag™ SCX 磁珠 250mg | 250mg | 5175 |
| FV104 | 5µm BcMag™ SCX 磁珠 500mg | 500mg | 9750 |
| DA101 | 1µm BcMag™ PEI 磁珠 250mg | 250mg | 5175 |
| DA102 | 1µm BcMag™ PEI 磁珠 500mg | 500mg | 9750 |
| DA103 | 5µm BcMag™ PEI磁珠 250mg | 250mg | 5175 |
| DA104 | 5µm BcMag™ PEI 磁珠 500mg | 500mg | 9750 |
| FO101 | 1µm BcMag™ 羟基磷灰石磁珠 250mg | 250mg | 5175 |
| FO102 | 1µm BcMag™ 羟基磷灰石磁珠 500mg | 500mg | 9750 |
| FK101 | 1µm BcMag™ C-8 磁珠 250mg | 250mg | 5175 |
| FK102 | 1µm BcMag™ C-8 磁珠 500mg | 500mg | 9750 |
| FK103 | 5µm BcMag™ C-8 磁珠 250mg | 250mg | 5175 |
| FK104 | 5µm BcMag™ C-8 磁珠 500mg | 500mg | 9750 |
| FL101 | 1µm BcMag™ C-18 磁珠 250mg | 250mg | 5175 |
| FL102 | 1µm BcMag™ C-18 磁珠 500mg | 500mg | 9750 |
| FL103 | 5µm BcMag™ C-18 磁珠 250mg | 250mg | 5175 |
| FL104 | 5µm BcMag™ C-18 磁珠 500mg | 500mg | 9750 |
| FS101 | 1µm BcMag™ C-4 磁珠 250mg | 250mg | 5175 |
| FS102 | 1µm BcMag™ C-4 磁珠 500mg | 500mg | 9750 |
| FS103 | 5µm BcMag™ C-4 磁珠 250mg | 250mg | 5175 |
| FS104 | 5µm BcMag™ C-4 磁珠 500mg | 500mg | 9750 |
| FS105 | 1µm BcMag™ 氰基丙基磁珠 250mg | 250mg | 5175 |
| FS106 | 1µm BcMag™ 氰基丙基磁珠 500mg | 500mg | 9750 |
| FS107 | 5µm BcMag™ 氰基丙基磁珠 250mg | 250mg | 5175 |
| FS108 | 5µm BcMag™ 氰基丙基磁珠 500mg | 500mg | 9750 |
| FT101 | 1µm BcMag™ 苯环基磁珠 250mg | 250mg | 5175 |
| FT102 | 1µm BcMag™ 苯环基磁珠 500mg | 500mg | 9750 |
| FT103 | 5µm BcMag™ 苯环基磁珠 250mg | 250mg | 5175 |
| FT104 | 5µm BcMag™ 苯环基磁珠 500mg | 500mg | 9750 |
| FT105 | 1µm BcMag™ 二苯基磁珠 250mg | 250mg | 5175 |
| FT106 | 1µm BcMag™ 二苯基磁珠 500mg | 500mg | 9750 |
| FT107 | 5µm BcMag™ 二苯基磁珠 250mg | 250mg | 5175 |
| FT108 | 5µm BcMag™ 二苯基磁珠 500mg | 500mg | 9750 |
| AY101 | BcMag™ 高纯度质粒提取试剂盒 5ml | 5ml | 4125 |
| AY102 | BcMag™ 高纯度质粒提取试剂盒 10ml | 10ml | 7875 |
| CA101 | BcMag™ 快速 Oligo-DNA偶联试剂盒 100mg Beads Kit | 100mg Beads Kit | 5400 |
| CA102 | BcMag™ 快速 Oligo-DNA偶联试剂盒 200mg Beads Kit | 200mg Beads Kit | 9750 |
| CA103 | BcMag™ RNA-DNA偶联试剂盒 100mg Beads Kit | 100mg Beads Kit | 5400 |
| CA104 | BcMag™ RNA-DNA偶联试剂盒 200mg Beads Kit | 200mg Beads Kit | 9750 |
| MMS101 | BcMag™ 快速mRNA提取纯化试剂盒 Kit | Kit | 4800 |
| MMS102 | BcMag™ Oligo-dT 磁珠 4ml | 4ml | 5700 |
| BA101 | BcMag™ 一步法脂质清除试剂盒 1ml | 1ml | 2250 |
| BA102 | BcMag™ 一步法脂质清除试剂盒 5ml | 5ml | 10350 |
| BB101 | BcMag™ 一步法脱蛋白清除试剂盒 1ml | 1ml | 2250 |
| BB102 | BcMag™ 一步法脱蛋白清除试剂盒 5ml | 5ml | 10350 |
| BC101 | BcMag™ 一步法SDS清除试剂盒 1ml | 1ml | 2250 |
| BC102 | BcMag™ 一步法SDS清除试剂盒 5ml | 5ml | 10350 |
| BD101 | BcMag™ 一步法去垢剂清除试剂盒 1ml | 1ml | 2250 |
| BD102 | BcMag™ 一步法去垢剂清除试剂盒 5ml | 5ml | 10350 |
| BE101 | BcMag™ 快速白蛋白清除试剂盒 25x preps Kit | 25x preps Kit | 3750 |
| BE102 | BcMag™ 快速白蛋白清除试剂盒 2.5ml beads, 100x preps | 2.5ml beads, 100x preps | 9750 |
| BF101 | BcMag™ 快速 HSA-IgG清除试剂盒 25x preps Kit | 25x preps Kit | 3750 |
| BF102 | BcMag™ 快速 HSA-IgG清除试剂盒 2.5ml beads, 100x preps | 2.5ml beads, 100x preps | 9750 |
| BG101 | BcMag™ 一步法染料清除试剂盒 1ml | 1ml | 2250 |
| BG102 | BcMag™ 一步法染料清除试剂盒 5ml | 5ml | 10350 |
| BH101 | BcMag™ 固定化TCEP二硫化物还原试剂盒 100mg | 100mg | 3750 |
| BH102 | BcMag™ 固定化TCEP二硫化物还原试剂盒 500mg | 500mg | 6750 |
| MKE101 | BcMag™ 快速内毒素清除试剂盒 Kit | Kit | 5250 |
| MKE102 | BcMag™ 快速内毒素清除试剂盒 5ml Beads | 5ml Beads | 7425 |
| MKE103 | BcMag™ 快速内毒素清除试剂盒 20ml of 10x regeneration buffers | 20ml of 10x regeneration buffers | 2535 |
| FQ101 | BcMag™ EDTA金属离子清除试剂盒 150mg | 150mg | 4125 |
| FQ102 | BcMag™ EDTA金属离子清除试剂盒 300mg | 300mg | 7875 |
| BI101 | BcMag™ EGTA金属离子清除试剂盒 150mg | 150mg | 4125 |
| BI102 | BcMag™ EGTA金属离子清除试剂盒 300mg | 300mg | 7875 |

艾美捷科技代理Nexcelom品牌。
2003年,Nexcelom的创始人推出了CP2,这是一种辅助手动细胞计数的方便工具。Nexcelom的创始人兼首席技术官JeanQiu博士说,“NIH的某位客户曾要求我们‘消除显微镜计数’。
为此,我们发明了CellometerAutoT4,用于测量细胞浓度和活力。”自那时起,Nexcelom扩大了产品范围,升级了系统功能,并优化了适用的方法,使研究人员能够分析所有细胞类型,
包括小细胞和原代细胞。凭借先进的专有技术,Nexcelom是细胞分析中基于图像的细胞计数的领导者和创新者。世界各地的科学家在学术和政府研究机构、生物技术和工业环境中使用
Cellometer,Cellaca和Celigo仪器进行细胞定量、分析和基于细胞的检测。Nexcelom图像细胞术和细胞分析解决方案被集成到生命科学的广泛工作流程中。
< " data-original="http://bellbrook.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Nexcelom品牌"> 艾美捷科技代理Nexcelom品牌
Vally Biomedical自1986年建立之初,就开始为客户提供高质量的生物、诊断试剂,并进行合作生产。1995年,Valley Biomedical利用自身的技术经验,为研发客户提供一些列人和动物源的血液制品和细胞培养血清等产品。
Valley Biomedical was established in 1986 to service the Clinical Diagnostics Industry with high quality biologicals, diagnostic reagent products and contract manufacturing services. Around 1995 we began to utilize our depth of experience and concentrate on providing a line of Human and Animal source blood products and cell culture sera to the R&D market.
Valley Biomedical的主要产品包括:
(1)CELL CULTURE
Human Serum
Fetal Bovine Serum
Other Animal Sera
Albumin
Liquid Media Products
(2)Human Products
Human Blood
Human Plasma
Human Serum
Other Human Prod.
(3)Animal Products
Dog
Rat
Mouse
Rabbit
Monkey
Guinea Pig
Equine
Sheep
Minipig
Porcine
Other
(4)REAGENTS
Aqueous Solutions
Media
Clinical Lab Products
Contract Manufacturer
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

艾美捷科技代理Berry & Associates全系列修饰核苷酸等
美国 Berry & Associates 公司成立于1989年,提供近200种亚磷酰胺和核苷酸合成用固相交联单体,以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。
Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.







Berry & Associates的主要产品包括:
| 产品名称 | 产品编号 | 纯度 | 规格 |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2'-3'-Dideoxyguanosine | PR 3505 | ≥95% | 25 mg; 100 mg |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 2',3'-Dideoxyuridine | PY 7278 | ≥97% | 100 mg; 500 mg |
| 2',3'-Didehydro-2',3'-dideoxyuridine | PY 7279 | ≥97% | 25 mg; 100 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| 2-Amino-2'-deoxyadenosine | PR 3060 | ≥97% | 1 g; 5 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine | PR 3080 | ≥95% | 100 mg; 1 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-isobutyryl-2'-deoxyadenosine | PR 3130 | ≥95% | 100 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3670 | ≥95% | 100 mg; 1 g |
| 2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine | PR 3070 | ≥97% | 25 mg; 100 mg |
| 2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine | PR 3160 | ≥97% | 100 mg; 250 mg |
| 2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate | PR 3180 | ≥97% | 25 mg; 100 mg |
| 2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3680 | ≥97% | 100 mg; 1 g |
| 6-N-Acyl-6-N-methyl-2'-deoxyadenosine | PR 3006 | ≥95% | 25 mg; 100 mg |
| 8-Amino-2'-deoxyadenosine | PR 3115 | ≥97% | 10 mg; 100 mg |
| N6-(6-Aminohexyl)-2'-deoxyadenosine | PR 3120 | ≥90% | 100 mg; 1 g |
| 8-Azido-2'-deoxyadenosine | PR 3125 | ≥97% | 10 mg; 100 mg |
| N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine | PR 3230 | ≥95% | 50 mg; 250 mg |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine | PR 3260 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| 8-Benzyloxy-2'-deoxyadenosine | PR 3280 | ≥97% | 100 mg; 1 g |
| 8-Bromo-2'-deoxyadenosine | PR 3290 | ≥90% | 2 g; 10 g |
| 8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3320 | ≥95% | 100 mg; 1 g |
| 8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3340 | ≥97% | 0g (discontinued); |
| 2'-Deoxyadenosine Monohydrate | PR 3445 | ≥97% | 25 g; 100 g |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2-Fluoro-2'-deoxyadenosine | PR 3496 | ≥97% | 25 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| N6-Methyl-2'-deoxyadenosine | PR 3740 | ≥97% | 100 mg; 1 g |
| 4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine | PRA 10012 | ≥95% | 10 mg; 50 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| 7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine | PRA 10032 | ≥95% | 10 mg; 50 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 8-Allyloxy-2'-deoxyguanosine | PR 3010 | ≥90% | 0Discontinued; |
| 8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3015 | ≥90% | 1 g; 10 g |
| 8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3020 | ≥90% | 1 g; 10 g |
| 5'-Azido-5'-deoxyguanosine | PR 3225 | ≥90% | 5 mg; 10 mg |
| 8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3285 | ≥90% | 1 g; 10 g |
| 8-Bromo-2'-deoxyguanosine | PR 3300 | ≥90% | 1 g; 5 g |
| 8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine | PR 3310 | ≥97% | 500 mg; 1 g |
| 8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3330 | ≥90% | 250 mg; 1 g |
| 5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine | PR 3335 | ≥95% | 100 mg; 1 g |
| 2'-Deoxyguanosine monohydrate | PR 3452 | ≥97% | 10 g; 100 g |
| α-2'-Deoxyguanosine | PR 3455 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine | PR 3600 | ≥97% | 100 mg; 1 g |
| 3',5'-Di-O-acetyl-2'-deoxyguanosine | PR 3605 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine | PR 3630 | ≥97% | 100 mg; 1 g |
| N2-Ethyl-2'-deoxyguanosine | PR 3700 | ≥95% | 25 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| N2-Isobutyl-2'-deoxyguanosine | PR 3745 | ≥97% | 10 mg; 100 mg |
| N1-Methyl-2'-deoxyguanosine | PR 3748 | ≥97% | 25 mg; 1 g |
| N2-Methyl-2'-deoxyguanosine | PR 3750 | ≥97% | 25 mg; 100 mg |
| O6-Methyl-2'-deoxyguanosine | PR 3755 | ≥90% | 5 mg; 25 mg |
| 6-Thio-2'-deoxyguanosine | PR 3845 | ≥97% | 10 mg; 100 mg |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 2'-O-Methyladenosine | PR 3734 | ≥97% | 1 g; |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-thiouridine | PY 7575 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-(methylithio)uridine | PY 7577 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine | PR 3000 | ≥97% | 25 mg; 250 mg |
| 3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine | PR 3200 | ≥90% | 50 mg; 250 mg |
| 3'-Azido-2',3'-dideoxyadenosine | PR 3210 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-2',3'-dideoxyguanosine | PR 3220 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| N6-Benzoyl-3'-deoxyadenosine | PR 3240 | ≥97% | 100 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine | PR 3250 | ≥97% | 100 mg; 1 g |
| 3'-Deoxyadenosine | PR 3430 | ≥97% | 10 mg; 100 mg |
| 3'-Deoxyguanosine | PR 3460 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine | PR 3590 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-3'-deoxyguanosine | PR 3690 | ≥97% | 20 mg; 100 mg |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine | PY 7230 | ≥97% | 100 mg; |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3040 | ≥97% | 1 g; |
| 2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3045 | ≥95% | 1 g; |
| 2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine | PR 3050 | ≥95% | 5 g; 25 g |
| 6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3370 | ≥97% | 100 mg; 1 g |
| 6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3380 | ≥90% | 100 mg; 1 g |
| 6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine | PR 3390 | ≥97% | 0 g; |
| 6-Chloro-9-(β-D-ribofuranosyl)purine | PR 3400 | ≥97% | 5 g; 10 g |
| Adenosine | PR 3005 | ≥97% | 100 g; 1 kg |
| 8-Methyladenosine | PR 3007 | ≥95% | 25 mg; 100 mg |
| Vidarabine | PR 3008 | ≥97% | 1 g; 5 g |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| N1-Methyladenosine hydroiodide | PR 3032 | ≥95% | 100 mg; 1 g |
| 2-Methyladenosine | PR 3035 | ≥97% | 10 mg; 25 mg |
| 5'-Chloro-5'-deoxyadenosine | PR 3360 | ≥97% | 100 mg; 1 g |
| N6-Methyladenosine | PR 3732 | ≥97% | 100 mg; 1 g |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10000 | ≥97% | 100 mg; 1 g |
| 2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10005 | ≥97% | 500 mg; 1 g |
| 4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine | PRA 10006 | ≥90% | 25 mg; 100 mg |
| 8-Azaadenosine | PRA 10007 | ≥97% | 20 mg; |
| 8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine) | PRA 10008 | ≥95% | 10 mg; 100 mg |
| 4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine | PRA 10009 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-7-deaza-2'-deoxyadenosine | PRA 10010 | ≥97% | 100 mg; 1 g |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; 1 g |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine | PRA 10020 | ≥97% | 100 mg; 1 g |
| 3-Deaza-2'-deoxyadenosine | PRA 10025 | ≥97% | 25 mg; 100 mg |
| 7-Deaza-2'-deoxyadenosine | PRA 10030 | ≥97% | 100 mg; 1 g |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 7-Deaza-2'-deoxyguanosine | PRA 10040 | ≥97% | 100 mg; 1 g |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 7-Deaza-2'-deoxyxanthosine | PRA 10050 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine | PRA 10055 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10100 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10110 | ≥97% | 100 mg; 1 g |
| Sangivamycin | PRA 10140 | ≥97% | 10 mg; 25 mg |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; 100 mg |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| dNaM | FC 8110 | ≥97% | 25 mg; 100 mg |
| 9-Deaza-2'-deoxyguanosine | PRA 10120 | ≥97% | 10 mg; 100 mg |
| 9-Deazaguanosine | PRA 10130 | ≥97% | 10 mg; 100 mg |
| 2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine | PYA 11000 | ≥97% | 10 mg; 25 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| 2'-Deoxypseudoisocytidine | PYA 11005 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudouridine | PYA 11010 | Purity: ≥97% | 25 mg; |
| 5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine | PYA 11035 | Purity: ≥97% | 50 mg; 100 mg |
| 1,3-Dimethyl-2'-deoxypseudouridine | PYA 11040 | ≥97% | 10 mg; 100 mg |
| 1,3-Dimethylpseudouridine | PYA 11050 | ≥97% | 10 mg; 50 mg |
| N1-Methylpseudouridine | PYA 11052 | ≥95% | 10 mg; 50 mg |
| N3-Methylpseudouridine | PYA 11054 | ≥97% | 10 mg; 25 mg |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Pseudoisocytidine hydrochloride | PYA 11060 | ≥97% | 10 mg; 100 mg |
| Pseudothymidine | PYA 11070 | ≥97% | 10 mg; 100 mg |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; 50 mg |
| 3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine | PR 3350 | ≥97% | 10 mg; |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-Deoxy-8,5'-cycloadenosine | PR 3440 | ≥97% | 10 mg; 100 mg |
| 2',5'-Dideoxy-8,5'-cycloadenosine | PR 3500 | ≥97% | 10 mg; |
| 2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine | PR 3730 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-8,5'-cycloadenosine | PR 3800 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-2'-deoxy-8,5'-cycloadenosine | PR 3810 | ≥97% | 10 mg; |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine | PY 7054 | ≥97% | 25 mg; 100 mg |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 5-Bromo-2'-deoxycytidine | PY 7115 | ≥97% | 1 g; 10 g |
| Cytidine | PY 7215 | ≥97% | 50 g; 500 g |
| 2'-Deoxycytidine | PY 7216 | ≥97% | 10 g; 50 g |
| 2'-Deoxycytidine Hydrochloride | PY 7217 | ≥97% | 5 g; 50 g |
| 5'-Azido-2',5'-dideoxycytidine | PY 7219 | ≥97% | 25 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| N4-Ethyl-2'-deoxycytidine | PY 7245 | ≥97% | 100 mg; 250 mg |
| 5-Methyl-2'-deoxyisocytidine | PY 7255 | ≥95% | 500 mg; 1 g |
| 6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7270 | ≥97% | 20 mg; 50 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7380 | ≥97% | 50 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine | PY 7410 | ≥97% | 100 mg; |
| 6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one | PY 7540 | ≥95% | 250 mg; 500 mg |
| Cytidin-5-yl-methanesulfonate sodium salt hydrate | PY 7586 | ≥95% | 50 mg; 100 mg |
| 5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine | PY 7587 | ≥97% | 10 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxycytidine | PY 7588 | ≥97% | 50 mg; 100 mg |
| 5-Formyl-2'-deoxycytidine | PY 7589 | ≥97% | 5 mg; 10 mg |
| 5-Carboethoxy-2'-deoxycytidine | PY 7592 | ≥95% | 25 mg; 100 mg |
| 2'-Deoxycytidine-5-carboxylic acid, sodium salt | PY 7593 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxymethylcytidine | PY 7596 | ≥97% | 50 mg; 100 mg |
| Cytidine-5-carboxylic acid, sodium salt | PY 7598 | ≥97% | 10 mg; 50 mg |
| 5-Formylcytidine | PY 7599 | ≥97% | 5 mg; 10 mg |
| 5-Iodo-2'-deoxycytidine | PY 7607 | ≥97% | 2 g; 10 g |
| 5-Iodocytidine | PY 7609 | ≥97% | 5 g; |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Methyl-2'-deoxycytidine Hydrochloride | PY 7635 | ≥97% | 0.25 g; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methylcytidine | PY 7637 | ≥97% | 1 g; 5 g |
| N4-Methylcytidine | PY 7638 | ≥97% | 25 mg; 100 mg |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 2-Thiocytidine | PY 7721 | ≥97% | 10 mg; 100 mg |
| 2-Thio-2'-deoxycytidine | PY 7723 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| 8-Hydroxyguanosine | PR 3795 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 5-Aza-2'-deoxycytidine | PY 7105 | ≥95% | 25 mg; 100 mg |
| 5,6-Dihydro-5-aza-2'-deoxycytidine | PY 7106 | ≥97% | 25 mg; 100 mg |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| Nap-dU | PY 7735 | ≥97% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 8-18O-Hydroxyguanosine | IOPR 3795 | ≥95% | 2 mg; 5 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| N2-Dimethylguanosine | PR 3702 | ≥97% | 10 mg; 100 mg |
| Guanosine | PR 3703 | ≥97% | 100 g; 500 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| O6-Methylguanosine | PR 3757 | ≥97% | 25 mg; 100 mg |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 8-Bromoguanosine | PR 3796 | ≥97% | 0 g; |
| 8-Benzyloxyguanosine | PR 3797 | ≥95% | 100 mg; 1 g |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 2'-Deoxy-4-desmethylwyosine | PR 3450 | ≥95% | 100 mg; 500 mg |
| 2'-Deoxyinosine | PR 3463 | ≥97% | 10 g; 100 g |
| 5'-Azido-2',5'-dideoxyinosine | PR 3464 | ≥97% | 5 mg; 25 mg |
| 3',5'-Di-O-acetyl-2'-deoxyinosine | PR 3480 | ≥97% | 1 g; |
| 3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine | PR 3490 | ≥90% | 1 g; |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| 5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine | PR 3660 | ≥97% | 100 mg; 1 g |
| Inosine | PR 3725 | ≥97% | 100 g; 500 g |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| O6-Phenyl-2'-deoxyinosine | PR 3840 | ≥97% | 100 mg; 1 g |
| 2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3842 | ≥97% | 25 mg; |
| 5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3843 | ≥90% | 25 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine | PR 3510 | ≥90% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3520 | ≥95% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3530 | ≥90% | 100 mg; 1 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| d5SICS | FC 8120 | ≥97% | 25 mg; 100 mg |
| AICA Riboside (AICAR) | MN 20001 | ≥97% | 0 g (DISCONTINUED); |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine | PR 3692 | ≥95% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| tC Nucleoside | PYA 11110 | ≥97% | 50 mg; 100 mg |
| tCnitro Nucleoside | PYA 11115 | ≥95% | 5 mg; 25 mg |
| 2'-Deoxynebularine | PR 3470 | Purity: ≥97% | 100 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole | PYA 11020 | ≥97% | 50 mg; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole | PYA 11030 | ≥95% | 100 mg; |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; |
| 5'-Amino-5'-deoxythymidine | PY 7030 | ≥97% | 25 mg; 50 mg |
| O2,5'-Anhydrothymidine | PY 7060 | ≥95% | 500 mg; 1 g |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 5'-Azido-5'-deoxythymidine | PY 7070 | ≥97% | 25 mg; 100 mg |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7120 | ≥97% | 1 g; |
| 3'-O-(t-Butyldimethylsilyl)thymidine | PY 7130 | ≥95% | 500 mg; 1 g |
| 5'-O-(t-Butyldimethylsilyl)thymidine | PY 7140 | ≥97% | 5 g; 10 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)thymidine | PY 7150 | ≥97% | 1 g; 5 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine | PY 7160 | ≥95% | 100 mg; 500 mg |
| S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine | PY 7200 | ≥95% | 10 mg; 100 mg |
| S4-(2-Cyanoethyl)-4-thiothymidine | PY 7210 | ≥95% | 10 mg; 100 mg |
| 5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7250 | ≥97% | 1 g; |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one | PY 7315 | ≥90% | 1 g; 10 g |
| 2',3'-Didehydro-3'-deoxythymidine | PY 7328 | ≥95% | 10 mg; 100 mg |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| 5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine | PY 7510 | ≥97% | 50 mg; 100 mg |
| 2-O-Ethylthymidine | PY 7561 | ≥97% | 500 mg; 1 g |
| 5'-Iodo-5'-deoxythymidine | PY 7610 | ≥97% | 250 mg; 1 g |
| 5'-O-Methylthymidine | PY 7680 | ≥95% | 50 mg; 100 mg |
| 2-Thiothymidine | PY 7725 | ≥95% | 20 mg; 100 mg |
| Thymidine | PY 7727 | ≥97% | 25 g; 250 g |
| 5'-O-(p-Toluenesulfonyl)thymidine | PY 7740 | ≥97% | 5 g; |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5'-Trifluoroacetamido-5'-deoxythymidine | PY 7750 | ≥97% | 50 mg; |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 6-Azathymidine | PYA 11058 | ≥95% | 25 mg; 100 mg |
| NPOM-Caged-dT CEP | BA 0317 | ≥95% | 100 µmol; 0.25 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 5-Ethynyl uridine CEP | BA 0353 | ≥90% | 100 µmol; 0.25 g |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 5-(Furan-2-yl)-2'-deoxyuridine | PY 7053 | ≥97% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one | PY 7055 | ≥97% | 20 mg; 100 mg |
| 5-Bromo-2'-deoxyuridine | PY 7117 | ≥97% | 10 g; 25 g |
| 5-Bromouridine | PY 7118 | ≥95% | 5 g; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carbomethoxyvinyl)uridine | PY 7172 | ≥97% | 25 mg; 250 mg |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)uridine | PY 7185 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine | PY 7212 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 2'-Deoxyuridine | PY 7275 | ≥97% | 25 g; 100 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine | PY 7280 | ≥95% | 100 mg; 500 mg |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7310 | ≥97% | 20 mg; 50 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine | PY 7450 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5-Methoxymethyl-2'-deoxyuridine | PY 7465 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-Ethynyl-2'-deoxyuridine | PY 7562 | ≥97% | 25 mg; 100 mg |
| 5-Ethynyl uridine | PY 7563 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-deoxyuridine | PY 7565 | ≥97% | 100 mg; 1 g |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7580 | ≥97% | 25 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7590 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Acetoxymethyl-2'-deoxyuridine | PY 7604 | ≥97% | 25 mg; 100 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 2'-Fluoro-5'-iodo deoxyuridine | PY 7612 | ≥95% | 100 mg; |
| 5-Iodo-2'-deoxyuridine | PY 7615 | ≥97% | 10 g; 25 g |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 5-Iodouridine | PY 7632 | ≥95% | 5 g; 25 g |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 3-Methyluridine | PY 7694 | ≥97% | 25 mg; 100 mg |
| 5-Methyluridine | PY 7695 | ≥97% | 200 mg; 1 g |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 5-(Propargyloxy)-2'-deoxyuridine | PY 7712 | ≥95% | 10 mg; 100 mg |
| Zebularine | PY 7715 | ≥97% | 10 mg; 25 mg |
| 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine | PY 7720 | ≥90% | 500 mg; 1 g |
| 2-Thiouridine | PY 7724 | ≥97% | 25 mg; 100 mg |
| 5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine | PY 7730 | ≥97% | 1 g; 5 g |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine | PY 7758 | ≥97% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| 5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine | PY 7775 | ≥97% | 100 mg; 1 g |
| Uridine | PY 7780 | ≥97% | 100 g; 500 g |
| 2'3'-O-Isopropylidene uridine | PY 7781 | ≥97% | 5 g; 25 g |
| 5-Hydroxymethyl uridine | PY 7782 | ≥97% | 50 mg; 100 mg |
| 5-Methoxyuridine | PY 7783 | ≥97% | 10 mg; 50 mg |
| 6-Aza-2'-deoxyuridine | PYA 11057 | ≥95% | 50 mg; 100 mg |
" data-original="http://bellbrook.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸

Zedira是一家临床阶段的生物技术公司,专门从事转谷氨酰胺酶的研究,开发一系列小分子药物候选物。Zedira公司正致力于药物发现的前沿领域,该领域涉及阻止调节失调的转谷氨酰胺酶的小分子。此外,Zedira是一个全球品牌,专门用于转谷氨酰胺酶领域的研发和诊断试剂,其独特和高质量的产品有助于推动转谷氨酰胺酶的研究和应用。
Zedira is a clinical stage biotech company specialised in transglutaminase. Zedira conducts its own development of small molecular drug candidates. In doing so, the company is working at the cutting edge of drug discovery involving small molecules that block dysregulated transglutaminases. In addition, Zedira is a global brand for specialty reagents for research & development as well as diagnostics in the transglutaminase field. Numerous unique and high quality products help pushing forward transglutaminase-related science – both in academia and industry.
Zedira公司主要产品:
Transglutaminases
Microbial Transglutaminase
Assays and Substrates
Inhibitors
Antibodies and Microarrays
Proteases
Protein Labeling
Blood Coagulation
Cereal Proteins
Celiac Disease Products
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
Zedira产品详情请咨询我司客服人员:
| 产品编号 | 产品名称 | 产品规格 |
| A003 | Polyclonal antibody to human tissue transglutaminase (TG2) | 100 ug |
| A004 | Monoclonal antibody to tissue transglutaminase (TG2) | 100 ug |
| A008 | Polyclonal antibody to human transglutaminase 5 (TG5) | 500 ug |
| A011 | Monoclonal antibody to gliadin (clone XGY1) | 1 mg |
| A013 | Monoclonal antibody to gliadin (clone XGY7) | 1 mg |
| A014 | Polyclonal antibody to human tissue transglutaminase (TG2) | 500 ug |
| A015 | Polyclonal antibody to human epidermal transglutaminase (TG3) | 500 ug |
| A016 | Polyclonal antibody to human blood coagulation factor XIII (A-subunit) | 500 ug |
| A017 | Polyclonal antibody to human neuronal transglutaminase (TG6) | 500 ug |
| A018 | Polyclonal antibody to human keratinocyte transglutaminase (TGI) | 500 ug |
| A020 | Polyclonal antibody to microbial protransglutaminase (pro-MTG, pro-BTG) | 500 ug |
| A021 | Polyclonal antibody to human plasminogen (rhPLG) | 500 ug |
| A022 | Polyclonal antibody to human prostate transglutaminase (TG4) | 500 ug |
| A023 | Monoclonal antibody to N'-ly-L-glutamylpL-lysine-isopeptide bond | 100 ug |
| A024 | Monoclonal Antibody to microbial (bacterial) Transglutaminase | 100 ug |
| A028 | FITC-labeled polyclonal antibody to human TG2 | 200 ug |
| A029 | FITC-labeled polyclonal antibody to human TGI | 200 ug |
| A030 | FITC-labeled polyclonal antibody to human TG3 | 200 ug |
| A031 | FITC-labeled polyclonal antibody to human TG6 | 200 ug |
| A032 | FITC-labeled polyclonal antibody to human factor XIII (A-subunit) | 200 ug |
| A033 | Monoclonal antibody to human TG2 (Catalytic Domain, clone XTG17) | 200 ug |
| A034 | Monoclonal antibody to human TG2 (Beta Sheet Domain, clone XTG 1 1) | 200 ug |
| A035 | Monoclonal antibodies to gliadin (Set No 1) | 1 Set |
| A036 | Monoclonal antibody to human TG2 (Beta Barrel 1 Domain, clone XTG21) | 200 ug |
| A037 | Monoclonal antibody to human TG2 (Beta Barrel 2 Domain, clone XTG1 8) | 200 ug |
| A040 | Polyclonal antibody to human transglutaminase 7 (TG7) | 200 ug |
| A042 | Monoclonal antibody to human TGI (clone XTG3 1) | 200 ug |
| A044 | FITC-labeled polyclonal antibody to human TG5 | 200 ug |
| A046 | D-Dimer monoclonal mouse antibody, clone 3B6 | 100 ug |
| A047 | D-Dimer monoclonal mouse antibody, clone 1 D2 | 100 ug |
| A051 | Biotinylated polyclonal antibody to microbial transglutaminase (MTG) | 50 ug |
| A052 | Biotinylated polyclonal antibody to human factor XIII (A-subunit) | 50 ug |
| A053 | Biotinylated polyclonal antibody to human TG2 | 50 ug |
| A054 | Monoclonal antibody to gliadin (clone XGY6) | 1 mg |
| A057 | Monoclonal antibody to deamidated gliadin | 100 ug |
| A058 | Monoclonal antibody to gliadin (clone XGY5) | 1 mg |
| A059 | Monoclonal antibody to gliadin (clone XGY9) | 1 mg |
| A060 | Monoclonal antibody to gliadin (clone XGY10) | 1 mg |
| A061 | Monoclonal antibody to gliadin (clone XGY 1 6) | 1 mg |
| A062 | Monoclonal antibody to deamidated and non-deamidated gliadin | 100 ug |
| A063 | Monoclonal antibody to gliadin (clone XGY2) | 1 mg |
| A064 | Monoclonal antibody to gliadin (clone XGY4) | 1 mg |
| A065 | Monoclonal antibody to gliadin (clone XGY8) | 1 mg |
| A066 | Monoclonal antibody to gliadin (clone XGY 1 2) | 1 mg |
| A067 | Monoclonal antibody to gliadin (clone XGY 1 5) | 1 mg |
| A068 | Monoclonal antibody to gliadin (clone XGY 1 7) | 1 mg |
| A069 | Monoclonal antibody to gliadin (clone XGY23) | 1 mg |
| A070 | Monoclonal antibody to gliadin (clone XGY24) | 1 mg |
| A071 | Monoclonal antibody to hordein (clone XH4) | 1 mg |
| A072 | polyclonal antibody to mouse tissue Transglutaminse | 200 ug |
| A074 | Polyclonal antibody to human blood coagulation factor XIII (B-subunit) | 200 ug |
| A075 | FITC-labeled polyclonal antibody to mouse TG2 | 200 ug |
| A076 | DD-XLink-mab | 100 ug |
| A077 | FITC-labeled polyclonal antibody to human factor XIII (B-subunit) | 200 ug |
| A078 | Polyclonal antibody to human epidermal transglutaminase (TG3) Protein A | 250 ug |
| A079 | Biotin-DD-XLink-mab | 50 ug |
| A082 | Monoclonal antibody to human TG3 (clone XTG45) | 200 ug |
| A101 | FXIII-Assay Substance, Abz-NE(CAD-DNP)EQVSPLTLLK-OH | 10 mg |
| A102 | TG2-Assay Substance. Abz-APE(CAD-DNP)QEA-OH | 10 mg |
| A105 | NQEQVSPLTLLK, alpha2-Antiplasmin peptide (1-12) | 25 mg |
| A106 | (ATTO-48 8TM)cadaveri ne | 1 mg |
| A108 | Ac-(D)-Asp-MA-N le-Nle-Leu-Pro-Trp-Pro-OH | 5 mg |
| A109 | β-Amyloid peptide 1-42 (Aβ 1-42) | 1 mg |
| A112 | (ATTO-532)cadaverine | 1 mg |
| A113 | (ATTO-550)cadaverine | 1 mg |
| A114 | (AnO-647N)cadaverine | 1 mg |
| A115 | (ATTO-700)cadaverme | 1 mg |
| A125 | Factor XIII activation peptide | 10 mg |
| A132 | Ac-WALQRPHYSYPD | 10 mg |
| A139 | Monoclonal antibody to human TG6 (Catalytic Domain, clone XTG52) | 200 ug |
| A140 | Monoclonal antibody to human TG6 (Beta Barrel 1 Domain, clone XTG39) | 200 ug |
| A141 | Monoclonal antibody to human TG6 (Beta Barrel 1 Domain, clone XTG68) | 200 ug |
| A142 | Monoclonal antibody to human TG6 (Beta Barrel 2 Domain, clone XTG57) | 200 ug |
| A143 | Monoclonal antibody to microbial Transglutaminase (clone XM67) | 200 ug |
| A144 | Monoclonal antibody to microbial Transglutaminase (clone XM68) | 200 ug |
| A145 | Polyclonal Antibody to microbial Transglutaminase | 200 ug |
| A152 | 3-Azido-l -propanamine | 100 mg |
| A153 | 4-Azidobutan-l-amine | 100 mg |
| A154 | Monoclonal antibody to human factor XIII (Activation Peptide, clone XTG09) | 200 ug |
| A155 | Monoclonal antibody to human factor XIII (Catalytic Domain, clone XTG02) | 200 ug |
| B001 | Biotinyl-Thr-Val-GIn-GIn-Glu-Leu-OH | 5 mg 25 mg |
| B002 | N-(Biotinyl)cadaverine | 25 mg 100 mg |
| B003 | Boc-DON-Gln-lle-Val-OMez "Boc-DON” | 10 mg |
| B006 | Thr-Val-Gln-Gln-Glu-Leu-OH | 25 mg |
| B007 | Keratinocyte transglutaminase (TGI )-substrate-peptide K5 | 10 mg |
| B008 | Tissue transglutaminase (TG2)-substrate-peptide T26 | 10 mg |
| B009 | Epidermal transglutaminase (TG3)-substrate-peptide E51 | 10 mg |
| B010 | Blood coagulation FXIII-substrate-peptide Fl 1 KA | 10 mg |
| B013 | Neuronal transglutaminase (TG6)-substrate peptide Y25 | 10 mg |
| B014 | Transglutaminase 7 (TG7)-substrate peptide Z3S | 10 mg |
| B015 | Biotin-Ahx-MA-QPL-OMe | 10 mg |
| B017 | Microbial Transglutaminase (MTG)-substrate peptide M48 | 10 mg |
| B019 | Biotin-Ahx-QVPL-OMe | 10 mg |
| C001 | Z-GIn-Gly-OH | 1g |
| C002 | Z-GIn-Gly-CAD-DNS | 25 mg 100 mg |
| C074 | Z-Gln-Gly-CAD-(AnO-488) | 1 mg |
| C075 | Z-Gln-Gly-CAD-(ATTO-532) | 1 mg |
| C076 | Z-Gln-Gly-CAD-(AnO-550) | 1 mg |
| C077 | Z-Gln-Gly-CAD-(ATTO-647N) | 1 mg |
| C078 | Z-Gln-Gly-CAD-(AnO-700) | 1 mg |
| C079 | Z-GIn-Gly-PEG(3)-N3 | 25 mg |
| C080 | Z-Gln-Gly-PEG(11)-N3 | 25 mg |
| C090 | Z-GIn-Gly-CAD-TAMRA | 25 mg |
| C091 | Z-GIn-Gly-CAD-Biotin | 25 mg |
| C092 | Z-Gln-Gly-(PEG1,088), monodisperse | 25 mg |
| C093 | Z-Gln-Gly-(PEG5,000), polydisperse | 25 mg |
| C094 | Tosyl-ε-aminopentyl-CMK | 1 mg |
| C095 | Dansyl-ε-aminopentyl-CMK | 1 mg |
| C102 | MTG Blocker | 10 mg 25 mg |
| D001 | Dansyl-ε-aminohexanoyl-GIn-GIn-lle-Val-OH | 25 mg 100 mg |
| D002 | N-(2,4-Dinitrophenyl)cadaverine | 100 mg |
| D003 | 1,3-Dimethyl-2[(2-oxo-propyl)thio]imidazolium chloride | 100 mg |
| D004 | 1,3-Dimelhyl-4,5-diphenyl-2-[(2-oxopropyl)thio]imidazolium | 10 mg |
| D005 | Metalloprotease-Assay-Substance, DABCYL-Ser-Phe-EDANS | 2 mg |
| D006 | N-(Dansyl)cadaverine | 100 mg |
| D007 | Cadaverine | 100 mg |
| D008 | "DALP", DNP-aminohexanoic acid-Lys-aminopropanol | 5 mg |
| D009 | DALP-methyl carbamate | 5 mg |
| D0I 6 | LDN 27219 | 10 mg |
| E018 | ZediXclusive Tissue Transglutaminase EIA | 1 Kit |
| E021 | ZediXclusive Microbial Transglutaminase (MTG) ELISA | 1 Kit |
| E103 | ZediXclusive TG6-ab ELISA (IgA) | 1 Kit (96 wells) |
| E104 | ZediXclusive TG6-ab ELISA (IgG) | 1 Kit (96 wells) |
| F001 | FXIII-Assay Kit | 1 Kit |
| F002 | Tissue Transglutaminase Assay Kit | 1 Kit |
| F004 | Fibrinogen, purified from human plasma | 50 mg |
| F006 | FITC-labeled Fibrinogen | 5 mg |
| F007 | Fibrin Glue (porcine) | 1 Kit |
| F008 | Fibrin Glue (bovine) | 1 Kit |
| F011 | Cross-linked fibrin degradation products, xFDPs | 200 ug |
| F012 | Fibrin degradation products, FDPs | 200 ug |
| G001 | Alpha2-gliadin, 33mer (aa56-88), biotinylated | 5 mg |
| G002 | Deamidated alpha2-gliadin, 33mer (aa56-88), biotinylated | 5 mg |
| G003 | Ac-PLQPEQPFPK(ε-Biotin), Deamidated gliodin peptide | 10 mg |
| G004 | Ac-PEQLPQFEEK(ε-Biotin), Deamidated gliadin peptide | 10 mg |
| G005 | DGPx4 (Fusion protein of 4 deamidated gliadin peptides) | 500 ug |
| G006 | DGPx2 (Fusion protein of 2 deamidated gliadin peptides) | 500 ug |
| G007 | DGPxl (deamidated gliadin peptide) | 500 ug |
| G008 | Omega-5 gliadin | 500 ug |
| G009 | Alpha2-gliadin, 33mer (aa 56-88) | 5 mg |
| G011 | Deamidated alpha2-gliadin, 33mer, (Acetyl-aa56-88-amide, Q65E) | 5 mg |
| G013 | QPFPQPQLPYPQPQ-amide | 10 mg |
| G014 | QPFPQPELPYPQPQ-amide | 10 mg |
| G017 | Biotinylated DGPx1 | 100 ug |
| G018 | Barley albumin and globulin | 5 mg |
| G019 | Barley prolamin (Hordein) | 5 mg |
| G020 | Barley glutelin (Hordenin) | 5 mg |
| G021 | Rye albumin and globulin | 5 mg |
| G022 | Rye prolamin (Secalin) | 5 mg |
| G023 | Rye glutelin (Secalinin) | 5 mg |
| G024 | Corn albumin and globulin | 5 mg |
| G025 | Corn prolamin (Zein) | 5 mg |
| G026 | Corn glutelin (Zeanin) | 5 mg |
| G027 | Rice albumin and globulin | 5 mg |
| G028 | Rice prolamin (Oryzin) | 5 mg |
| G029 | Rice glutelin (Oryzenin) | 5 mg |
| G030 | Spell albumin and globulin | 5 mg |
| G031 | Spelt prolamin | 5 mg |
| G032 | Spelt glutelin | 5 mg |
| G033 | Oat albumin and globulin | 5 mg |
| G034 | Oat prolamin (Avenin) | 5 mg |
| G035 | Oat glutelin (Avenalin) | 5 mg |
| G036 | Wheat albumin and globulin (Leukosin and Edestin) | 5 mg |
| G037 | Wheat prolamin (Gliadin) | 5 mg |
| G038 | Wheat glutelin (Glutenin) | 5 mg |
| G039 | Durum wheat albumin and globulin | 5 mg |
| G040 | Durum wheat prolamin | 5 mg |
| G041 | Durum wheat glutelin | 5 mg |
| G042 | Soy protein, saline soluble fraction | 5 mg |
| G043 | Soy protein, ethanol soluble fraction | 5 mg |
| G044 | Soy protein, propanol/urea/DTE soluble fraction | 5 mg |
| G045 | Millet (Sorghum) albumin and globulin | 5 mg |
| G046 | Millet (Sorghum) prolamin (Kafirin) | 5 mg |
| G047 | Millet (Sorghum) glutelin | 5 mg |
| G048 | L-Glutamic acid γ-monohydroxamate | 100 mg |
| G051 | 26mer gliadin peptide | 250 ug |
| G052 | 33mer gliadin peptide | 250 ug |
| G054 | 33mer DGP | 250 ug |
| G055 | Carrier protein control | 250 ug |
| G056 | DGP and Gliadin peptides (Set No 1) | 1 Set |
| G057 | Alpha2-gliadin, 33mer (aa56-88), TAMRA labeled | 5 mg |
| G058 | Alpha2-gliadin, 33mer (aa56-88), TAMRA and Biotin labeled | 5 mg |
| G101 | Gly-Pro-Arg-Pro-amide | 25 mg |
| I001 | Involucrme, recombinant human | 500 ug |
| K004 | "KxD", Boc-Lys-en-DNS | 10 mg |
| L001 | Substrate Finder Kit | 1 Kit |
| L101 | Biotin TGase Protein Q-Labeling Kit | 1 Kit |
| L102 | PEG1,088 TGase Protein Q-Labeling Kit | 1 Kit |
| L103 | PEG5,000 TGase Protein Q-Labeling Kit | 1 kit |
| L104 | ATTO-488™ TGase Protein Q-Labeling Kit | 1 Kit |
| L105 | ATTO-532™ TGase Protein Q-Labeling Kit | 1 Kit |
| L106 | ATTO-550™ TGase Protein Q-Labeling Kit | 1 Kit |
| L107 | ATTO-647N™ TGase Protein Q-Labeling Kit | 1 Kit |
| L108 | ATTO-700™ TGase Protein Q-Labeling Kit | 1 Kit |
| L201 | Biotin TGase Protein K-Labeling Kit | 1 Kit |
| L202 | PEG1,088 TGase Protein K-Labeling Kit | 1 Kit |
| L203 | PEG5,000 TGase Protein K-Labeling Kit | 1 Kit |
| L204 | ATTO-488™ TGase Protein K-Labeling Kit | 1 Kit |
| L205 | ATTO-532™ TGase Protein K-Labeling Kit | 1 Kit |
| L206 | ATTO-550™ TGase Protein K-Labeling Kit | 1 Kit |
| L207 | ATTO-647N™ TGase Protein K-Labeling Kit | 1 Kit |
| L208 | ATTO-700™ TGase Protein K-Labeling Kit | 1 Kit |
| M001 | MTG-ANiTA-Kit | 1 Kit |
| M003 | Tissue Transglutaminase Pico-Assay Kit | 1 Kit |
| P003 | Prolylendopeptidase from Myxococcus xanthus, recombinant | 150U |
| P004 | PT-Gluten | 1 mg 10 mg |
| P009 | human Pro-Glu-Plasminogen, recombinant | 100 ug |
| P010 | (PEG1,088)amine, monodisperse | 10 mg |
| P011 | (PEG5,000)amine, polydisperse | 10 mg |
| P012 | human Plasmin, recombinant | 100 ug |
| P0U | Urokinase | 1 mg |
| P015 | Streptokinase (bacterial plasminogen activator) | 1 mg |
| P016 | Tissue Plasminogen Activator | 100 ug |
| P111 | PEPperCHIP Pan-Transglutaminase Microarray | 1 Chip |
| P112 | PEPperCHIP Custom Transglutaminase Microarray | 1 Chip |
| P113 | PEPperCHIP Transglutaminase Microarray Service | 1 Sample |
| P114 | PepSlide Analyzer | 3-Month/1-Year/Perpetual License |
| P115 | PEPperCHIP Incubation Tray 3/1 | 1 Tray |
| P116 | PEPperCHIP Staining Kit | 1 Kit |
| P117 | PEPperCHIP Transglutaminase 2 Microarray | 1 Chip |
| P118 | PEPperCHIP Incubation Tray 3/5 | 1 Tray |
| R001 | N-(Tetrametylrhodaminyl)cadaverine | 10 mg |
| R002 | TAMRA-DON | 5 mg 10 mg |
| T001 | Microbial (bacterial) transglutaminase | 25 U; 1 x 250 U;10x 25 U; lx 500 U; 20x 25 U |
| T002 | Human tissue transglutaminase (TG2) | 250 ug 1mg |
| T004 | N-(p-Tosyl)-Gly-Pro-Lys-pNA | 25 mg |
| T006 | Guinea pig liver transglutaminase | 10U |
| T009 | Human keratinocyte transglutaminase (TG1) | 150 ug |
| T011 | Human transglutaminase 7 | 250 ug |
| T013 | Human epidermal transglutaminase, Dispose activated | 200 ug |
| T016 | Microbial (bacterial) Pro-transglutaminase | 250 ug |
| T018 | Inactive human tissue transglutaminase | 250 ug 1 mg |
| T021 | Human neuronal transglutaminase (TG6) | 250 ug |
| T022 | Human tissue transglutaminase (TG2) | 250 ug 1 mg |
| T024 | Human epidermal transglutaminase (TG3) | 200 ug |
| T027 | Human blood coagulation Factor Xlll-A z recombinant | 200 ug |
| T034 | Human tissue transglutaminase (TG2) | 100 ug |
| T035 | Human keratinocyte transglutaminase (TGI) | 150 ug |
| T036 | Transglutaminase Assay Kit, fluorescent, Casein, Dansylcadaverine | 1 Kit |
| T038 | Rat tissue transglutaminase | 250 ug 1 mg |
| T039 | Guinea pig liver transglutaminase, recombinant | 10U |
| T040 | Mouse tissue transglutaminase | 250 ug 1 mg |
| T042 | Human prostate Transglutaminase (TG4) | 100 ug |
| T050 | Human blood coagulation Factor XIII B subunit | 200 ug |
| T051 | Open tTG™ | 250 ug |
| T055 | Tissue Transglutaminase Microassay Kit, colorimetric | 1 Kit |
| T056 | Human alpha thrombin, highly active | 200 U |
| T057 | Inhibited human epidermal transglutaminase | 250 ug |
| T061 | Mouse blood coagulation Factor Xlll-A2 | 200 ug |
| T062 | Dog blood coagulation Factor Xlll-A2 | 200 ug |
| T063 | Human blood coagulation Factor Xlll-A2 , Val34Leu-mutant | 200 ug |
| T064 | Inhibited human neuronal transglutaminase | 250 ug |
| T065 | Rat blood coagulation Factor Xlll-A2 | 200 ug |
| T066 | Pig blood coagulation Factor Xlll-A2 | 200 ug |
| T067 | Human tissue transglutaminase (TG2), endotoxin free | 250 ug 1 mg |
| T070 | Human Factor Xllla, Thrombin activated | 200 ug |
| T072 | Dog tissue transglutaminase | 250 ug 1 mg |
| T086 | Human Transglutaminase 5 | 100 ug |
| T087 | Tridegin | 200 ug |
| T092 | Human blood coagulation Factor Xlll-A2 | 100 ug |
| T101 | 1,3,4,5-Tetramethyl-2[(2-oxo-propyl)thio] imidazolium chloride | 10 mg |
| T102 | Mouse Open TG2 | 250 ug 1 mg |
| T106 | Biotinylated human tissue transglutaminase (TG2) | 100 ug 250 ug |
| T108 | Cynomolgus tissue transglutaminase | 250 ug |
| T109 | Cynomolgus open TG2 | 100 ug |
| T1 10 | Recombinant TG2 [E.coli] | 500 ug |
| T1 14 | Blood Coagulation Factor Xlll-Microassay Kit, colorimetric | 1 Kit |
| T117 | Biotinylated inactive hTG2 (Cys277Ser) | 250 ug 1 mg |
| T122 | Recombinant TG2 (insect cells) | 500 ug |
| T123 | Biotinylated human tissue transglutaminase (TG2) | 50 ug |
| T124 | Recombinant TG3 (insect cells) | 400 ug |
| T127 | Biotinylated human blood coagulation Factor XIII | 50 ug |
| T134 | Open tTG™ | 100 ug |
| T139 | Rabbit tissue transglutaminase | 250 ug 1mg |
| T140 | Biotinylated human epidermal transglutaminase | 100 ug |
| T141 | Biotinylated human neuronal transglutaminase | 100 ug |
| T142 | Biotinylated mouse blood coagulation Factor Xlll-A2 | 50 ug |
| T146 | Mouse neuronal transglutaminase | 250 ug |
| T148 | Biotinylated human Open tTG™ | 50 ug 1 mg |
| T149 | Oxidized inactive human tissue transglutaminase | 250 ug 1 mg |
| T150 | Biotinylated mouse open TG2 | 50 ug |
| T151 | Biotinylated oxidized inactive human tissue transglutaminase | 250 ug 1 mg |
| T152 | Rabbit blood coagulation Factor Xlll-A2 | 200 ug |
| T153 | Microbial (bacterial) transglutaminase, edotoxin free | 25 U;10x 25 U;20x 25 U |
| T156 | Biotinylated mouse tissue transglutaminase | 250 ug; 1 mg |
| T159 | Pig tissue transglutaminase | 250 ug; 1 mg |
| T160 | Biotinylated cynomolgus tissue transglutaminase | 50 ug |
| T161 | Cynomolgus blood coagulation Factor Xlll-A2 | 200 ug |
| T167 | Short human tissue transglutaminase, aa 1-475 | 250 ug |
| T168 | Human tissue transglutaminase, C23OA mutant | 250 ug;1 mg |
| T169 | Human tissue transglutaminase, R580A mutant | 250 ug;1 mg |
| T173 | Human tissue transglutaminase, R116C mutant | 1 mg |
| T178 | Microbial transglutaminase with C-terminal His6-tag | 25 U;10 x 25 U;20 x 25 U |
| T184 | Cat tissue transglutaminase | 200 ug |
| T187 | Factor XIII activation peptide, recombinant | 500 ug |
| T197 | Coagulation factor XIII, recombinant human Factor Xlll-A2 | 100E;250E |
| T222 | Human alpha Thrombin, recombinant | 100 NIH Units |
| Z004 | Z-Gln-GIn-Pro-Leu-OH | 25 mg |
| Z006 | Z-DON-Val-Pro-Leu-OMe,"Z-DON" | 10 mg |
| Z009 | ZediXclusive Microbial Transglutaminase Assay Kit | 1 Kit |
| Z010 | ZediXclusive Tissue Transglutaminase Assay Kit | 1 Kit |
| Z011 | Z-(D)-DON-Val-Pro-Leu-OMe | 10 mg |
| Z013 | Z-MA-QPL-OMe | 10 mg |
| Z015 | Keillor inhibitor AA9 | 10 mg |
| Z016 | Keillor inhibitor NC9 | 10 mg |
| Z017 | Keillor inhibitor VA4 | 10 mg |

艾美捷科技代理ZEUS Scientific 品牌。
ZEUS Scientific及其前身公司SurModics In Vitro Technologies于1979年成立,2007年合并了BioFX公司。ZEUS Scientific公司提供的产品种类丰富,涵盖多个科研和临床领域,主要包括:蛋白稳定剂(protein stabilization reagents)、比色底物及化学发光底物(colorimetric and chemiluminescent substrates)、DNA和蛋白芯片(activated slides for DNA and protein microarrays)和重组自身免疫抗原,以及辅助试剂,如二抗、封闭试剂、终止液等。此外,其产品还涉及分子生物学、细胞生物学、菌学、遗传学、生物化学、蛋白质学、细胞疗法、临床应用等多个领域。具体产品包括但不限于抗真菌素、维生素、氨基酸、核苷酸、脂类、糖类、白三烯、前列腺素、药理活性化合物、类固醇素结合物等生物分子,以及球蛋白、封闭肽、人蛋白和抗原、小鼠蛋白和抗原等多种蛋白质和抗原。

Molecular Innovations公司为全球的研究人员提供高质量的科研产品,包括纤溶酶原激活物抑制因子1,肾素,肾素原,玻连蛋白,纤维蛋白,纤维连接蛋白,血纤维蛋白溶酶原,血纤维蛋白溶酶,抗凝血酶,ELISA试剂盒,抗体和其他研究使用的试剂。
Molecular Innovations, founded in 1990, is a primary manufacturer of research antibodies, proteins and ELISA kits. We specialize in coagulation and thrombolysis reagents including PAI-1, tPA, urokinase, clotting factors, vitronectin, fibrinogen, fibronectin, clotting factors, prorenin/renin, albumin, and immunoglobulins. Our customers all over the world include pharmaceutical and biotechnology companies as well as major research institutions. We offer custom projects and bulk quotes. All products are manufactured under stringent quality control standards at our new state of the art facility in Novi, MI, USA.
Molecular innovations的主要产品包括:
Research Models
Molecular Biology
Purified Proteins
Elisa Kits
Monoclonal Antibodies
Polyclonal Antibodies
Inhibitors And Substrates
Chromatography Resins
Plasmas And Tissues
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:13212737804
传真:17754422825
邮箱:sales@amyjet.com
0.3252